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I-Abstract: 
 Apoptosis involves a series of biochemical events that leads to the eventual death of the 
cell. One pathway – intrinsic pathway, involves the fragmentation of mitochondria and the 
release of pro-apoptotic proteins, such as cytochrome c. A certain globin protein has been shown 
to be able to protect cells from apoptosis, called Neuroglobin (Ngb). Ngb is a globin haem 
protein that has been shown to reduce the ferric form of cytochrome c to inhibit apoptosis. In 
addition, Ngb has been shown to translocate into the mitochondria under stress, where it reacts 
with cytochrome c.  
Estradiol (E2) has been shown to greatly upregulate the levels of Ngb and also stimulates the 
translocation of Ngb into the mitochondria. The upregulation of Ngb has been shown to be 
mediated via the ER subtype, ERβ. Even though literature covers the effects of E2 and the ERβ 
agonist DPN (Diartylpropiolnitrile), there is a lack of evidence on the ER agonist, Resveratrol 
(RES); RES is a phytoestrogen that has been shown to induce mitochondrial biogenesis and 
abrogate mitochondrial fragmentation, ameliorating apoptosis. The hypothesis of this study is 
that RES will upregulate Ngb levels as E2 does, and will translocate Ngb into the mitochondria 
as E2 does.  
The results of this study showed that Ngb bands could not be detected via western blots, and the 
mRNA transcript levels in MCF-7 and DLD-1 could not be quantified. The Ngb-GFP fusion 
protein did not fluoresce and Ngb‘s translocation into the mitochondria could not be determined. 
Ngb overexpression did not inhibit mitochondrial fragmentation and did not induce 
mitochondrial fusion. 
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1.0 Introduction 
Apoptosis is programmed cell death, which can occur when a cell experiences various forms 
of stress, such as reactive oxygen species (ROS) (Gao et al., 2008). Apoptosis involves two 
major pathways: extrinsic and intrinsic pathways. The former involves death ligands (such as 
Tumour Necrosis Factor (TNF)) binding to death receptors which would lead to the activation of 
caspase 8 and the eventual activation of apoptosis. The latter is mediated by the release of pro-
apoptotic proteins, such as cytochrome c (cyt c) from the mitochondria into the cytoplasm. When 
these pro-apoptotic proteins are released, they activate a caspase cascade, which contributes to 
the regulated death of the cell (Figure 1.1). 
Multiple factors lead to the release of pro-apoptotic proteins from the mitochondria, 
including the peroxidation of the mitochondrial inner membrane phospholipid cardiolipin (CL). 
Cytoplasmic proteins also lead to the opening of pores and channels in the mitochondrial outer 
membrane, to aid in the release of the pro-apoptotic proteins. Another factor that aids the release 
of the pro-apoptotic proteins is calcium; calcium is normally released from the smooth 
endoplasmic reticulum and enters the mitochondria. The accumulation of the mitochondria 
causes swelling, which leads to mitochondrial fragmentation; the loss of mitochondrial 
membrane potential due to calcium occurs, leading to the opening of the mPTP (mitochondrial 
Permeability Transition Pore), aiding in the release of pro-apoptotic proteins as well. 
Estrogen receptors (ERs) are a group of receptors that affect the transcription of many genes 
(Nussey and Whitehead, 2013), when bound to their ligands. There are two different classes of 
ER: nuclear receptors (ERα and ERβ), and membrane receptors (mER) (Micevych and Kelly, 
2012; Soltysik and Czekaj, 2013), such as ER-X, Gq-mER and GPER (GPR30) (Prossnitz et al., 
2007). The ligand for these receptors is the steroid hormone estrogen, which is comprised of  
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estrone (E1), estradiol (E2) and estradiol (E3); E2 is the most predominant estrogen out of all 
three types. 
17β estradiol (E2) has been shown to promote antiapoptotic responses in cells (Nilsen and 
Brinton, 2003), and this effect is specific towards ERβ. The ERs act as receptors for exogenous 
ligands, in addition to the endogenous E2; a polyphenolic compound extracted from grapes, 
named Resveratrol (RES), has a binding affinity towards ERs, making it a phytoestrogen. 
Coincidentally, the effects of RES have been shown to be mediated via the ERβ (Wang et al., 
2013). A key downstream protein of the ERβ-mediated antiapoptic pathway is Neuroglobin 
(Ngb), which is greatly upregulated by E2 once it binds to ERβ. 
Neuroglobin is a globin protein found primarily in the nervous system, as well as non-
neuronal tissue, and has been shown in several studies to induce protection against hypoxia-
induced and oxidative stress-induced apoptosis. 
Figure 1.1 Intrinsic Apoptotic Pathway 
The figure depicts the intrinsic apoptotic pathway. The release of cytochrome c from 
the mitochondrion into the cytosol, leads to the formation of the apoptosome. The 
apoptosome activates procaspase-9 into caspase-9 that activates the caspase cascade, 
inexorably leading to apoptosis. The image was obtained from Logue and Martin, 2008. 
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Since Resveratrol has cytoprotective capabilities via ERβ binding, and that the upregulation 
of neuroglobin is ERβ-mediated, the hypothesis of this study is that Resveratrol would exert the 
same protective capabilities as E2 through neuroglobin upregulation. It is hypothesized that RES 
upregulates neuroglobin levels, and that this effect is ERβ-mediated. 
1.1 Literature Review 
1.1.1 Mitochondria 
Mitochondria are organelles that are responsible for ATP production (Gao et al., 2008; 
Celsi et al., 2009), calcium homeostasis (Celsi et al., 2009), redox signaling, reactive oxygen 
species (ROS) production (Gao et al., 2008; Vosler et al., 2009), and apoptosis (Vosler et al., 
2009).  Mutations in mitochondrial genes have been associated with hypertension, 
hypercholesterolemia, hypomagnesemia (Kim et al., 2008), cardiomyopathy, liver dysfunction, 
neurological disorders (Sharef et al., 2013) and reduced insulin secretion (Kim et al., 2008). 
 
1.1.2 Reactive Oxygen Species (ROS) and Reactive Nitrogen Species (RNS) 
Reactive Oxygen Species (ROS) is a group of reactive molecules, compromised of 
oxygen (Hayyan et al., 2016). They are normally produced as a result of oxygen usage within the 
mitochondria. ROS is normally produced at the last stage of respiration, where a few electrons 
―leak‖ to the final electron acceptor (oxygen), as they are being transported via the respiratory 
complexes. The main complexes for ROS production involve complex I and complex 
III (Nicolson, 2007; Li et al., 2013), particularly IF and IQ (Brand et al., 2016) sites of complex I 
and IIIQo site if complex III (Sena et al., 2012) (Figure 1.2). In addition to complexes I and III, 
the IIF site of complex II is also a ROS production site.  As electrons are being transported via 
the complexes, Oxygen will sometimes interact with the complexes prematurely, leading to the 
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formation of the superoxide radical anion (O2∙ −) (Matsuzaki et al., 2009). Superoxide radicals 
(O2•−) are then converted to different species, such as hydrogen peroxide (H2O2) and the 
hydroxyl radical (OH•); these different radicals are collectively known as ROS (Szeto, 
2006). Another type of reactive species, in the form of the peroxynitrite anion (ONOO−), is 
formed either when superoxide anions react with nitric oxide (NO) (Pacher et al., 2007.) or when 
H2O2 reacts with the nitrite anion (Robinson and Beckman, 2005.) which are collectively known 
as reactive nitrogen species (RNS).  
ROS can cause damage to DNA, proteins, and lipids due to its reactive nature (Cadenas 
and Davies, 2000). ROS also inhibits the electron transport chain, which is essential for 
production of ATP as part of the oxidative phosphorylation stage in respiration (Galkin and 
Moncada, 2007.). All cells have various means of detoxifying ROS to 
prevent excessive damage.  Enzymes that protect against ROS catalyze the conversion of 
superoxide to H2O2 via manganese superoxide dismutase (MnSOD) in the matrix, and the 
copper/zinc superoxide dismutase (Cu/ZnSOD) in the intermembrane space; the removal 
of H2O2 is catalyzed by catalase, peroxiredoxins  and glutathione peroxidase (Sivitz and Yorek, 
2010). Antioxidant molecules, such as ascorbic acid (vitamin C), glutathione (GSH) and 
tocopherols (vitamin E), are also important contributors to limiting ROS levels in and around 
cells (Karihtala and Soini, 2007). 
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1.1.3 Intrinsic Apoptotic Pathway 
The intrinsic apoptotic pathway involves the release of several proapoptotic proteins, 
such as cytochrome c (Cyt c), Apoptosis Initiation Factor (AIF) and SMAC/Diablo (Second 
Mitochondria-derived Activator of Caspases); the release of Cyt c and SMAC lead to the 
eventual activation of the proteolytic enzymes known as caspases (Kroemer and Reed, 2000). 
Cyt c, AIF and SMAC activate apoptosis through different mechanisms: Cyt c induces the 
allosteric activation of Apaf-1 (apoptosis-protease activating factor-1), which produces 
an apoptosome (Purring-Koch and McLendon, 2000). The apoptosome activates caspase-9, 
which in turn leads to the catalytic cleavage of caspase-3 and caspase 7 (Taylor et al., 2008; 
Ascenzi et al., 2011). However, SMAC activates the caspases by binding to and inhibiting the 
caspase inhibitor IAPs (Inhibitor of Apoptosis Proteins). In contrast, AIF does not activate 
caspases, but instead, it activates apoptosis when it moves into the nucleus from the cytoplasm to 
Figure 1.2 Electron Transport Chain in the Inner Mitochondrial Membrane 
The figure depicts the complexes embedded within the inner mitochondrial membrane 
that are responsible for transport of electrons. The sites at which ROS are produced are 
portrayed as the red shapes. The image was obtained from Orr et al., 2013. 
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start DNA fragmentation and chromosome condensation, initiating apoptosis (Yu et al., 2006). A 
member of the Bcl-2 family, Bax, aids in the release of the pro-apoptotic proteins. 
Bax is believed to induce the opening of VDAC (Voltage-dependent Anion Channel) (Shi 
et al., 2003) and MAC (Mitochondrial Apoptosis-induced Channel) (Buytaert et al., 2006); the 
opening of MAC (Dejean et al., 2006) and VDAC is said to aid in the release of the proapoptotic 
proteins from the mitochondria, which triggers apoptosis. This effect is enhanced due to the 
belief that p53 helps in the integration of Bax into the membrane of the mitochondria (Toshiyuki 
and Reed, 1995).  
The proapoptotic protein members of the Bcl-2 (B-cell/lymphoma 2) family generally 
induce pore openings in the membrane of the mitochondria (Green and Kroemer, 2004; Lutter et 
al., 2000; Kuwana et al., 2002); they regulate upstream events, relative to the mitochondria, and 
act based on whether cell death or survival is best, depending on the strength of the stress signal 
(Skommer et al., 2007); the intrinsic pathway is elucidated in Figure 1.3. The process could 
occur as part of embryogenesis, such as the separation of toes and fingers, but also due to cellular 
stress. Such stress could be caused by, for example, the accumulation of amyloid beta peptide, 
oxygen/glucose deprivation (OGD), increased levels of calcium, increased levels of ROS (Raha 
and Robinson, 2001; Galluzzi et al., 2009) or mitochondrial fragmentation; the mitochondrion is 
responsible for the mediation of the intrinsic apoptotic pathway (Green and Kroemer, 2004).  
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1.1.4 Cytochrome c 
Cytochrome c, a heme protein, is located between the inner and the outer membrane of 
the mitochondria and is responsible for transferring electrons from ubiquinone–cytochrome c 
reductase (Complex III) to cytochrome c oxidase (Complex IV); it is also responsible for the 
prevention of oxidative stress by scavenging O2∙ −  and H2O2 (Gnaiger 2003; Min and Jiang-
xing, 2007; Ow et al., 2008; Lenaz and Genova, 2010; Santucci et al., 2010; Ascenzi et al., 
2011). When cytochrome c is released into the cytosol, it binds with Apaf-1 and procaspase-9; 
the resulting complex, the apoptosome, initiates the activation of procaspase-9 to yield caspase-
Figure 1.3 Apoptotic Signalling Pathway 
The figure depicts both the extrinsic and the intrinsic apoptotic pathway. The right hand 
side of the figure shows the release of cytochrome c from the mitochondrion into the 
cytosol, forming the apoptosome. The apoptosome activates procaspase-9 into caspase-
9 that will eventually lead to apoptosis. The image was obtained from Yong-ling et al., 
2008. 
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9. This, in turn, initiates the catalytic cleavage of the effector caspase – caspase-3, which initiates 
the apoptotic pathway (Ascenzi et al., 2011). The release of cytochrome c has been also 
associated with the peroxidation of cardiolipin (Ott et al., 2002; Iverson and Orrenius, 2004; 
Nakagawa, 2004). Cardiolipin is a phospholipid that constitutes the inner membrane of the 
mitochondria, and has been suggested to aid in the release of cytochrome c (Green and Kroemer, 
2004). 
1.1.4.1 Cytochrome c and Cardiolipin 
Kagan et al., 2005 has shown that Cyt c itself catalyzes the peroxidization of CL, thereby 
leading to its own release. The normal tertiary structure of Cyt c has the heme iron group in the 
hexacoordinated configuration, which prevents access of H2O2 that is produced as a result of 
ROS catalytic enzymes, to the heme group. CL interaction with Cyt c exposes the heme iron 
group to H2O2, and once it binds to it, the peroxidase activity of Cyt c is induced (Kagan et al., 
2005). 
The reason Cyt c‘s heme iron group is not normally exposed to H2O2 is because all of the 
positions on the heme iron group are occupied when Cyt c is functioning as an electron shuttle 
between mitochondrial complexes III and IV. Hence, H2O2 cannot easily bind to it (Stellwagen, 
1968). The interaction between CL and Cyt c causes an unfolding in the structure of the latter, 
which seems to be as a result of the loss of the bond between the heme iron group and the amino 
acid residue Met80 (which acts as a ligand for the heme iron group) (Bernad et al., 2004; 
Tuominen et al., 2002; Nantes et al., 2001; Zucchi et al., 2003). The perxodiation of CL causes 
the detachment of Cyt c and the eventual release of Cyt c (Ott et al., 2002). 
1.1.5 Cardiolipin 
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Cardiolipin, a lipid that composes the inner mitochondrial membrane, has cytochrome c 
bound to it and allosterically changes the structure of Cyt c, changing its function from 
respiration to apoptosis (Ascenzi et al., 2011). 
The normal distribution of CL within the inner membrane of the mitochondria, between 
the matrix surface and the intermembrane surface is in a ratio of 60:40 (Garcia Fernandez et al., 
2002; Cossarizza et al., 2002). It has been shown however, that oxidative stress causes an 
increase in intermembrane surface CL distribution, and a decrease in CL distribution on the 
matrix surface, combined with an increase in CL distribution within the outer membrane (Kagan 
et al., 2005; Chu et al., 2013; De Arriba et al., 2013), hinting at the possibility of preparing for 
peroxidation to release Cyt c. 
The change in CL distribution within the membrane has been shown to occur before the 
loss of the mitochondrial membrane potential and after the production of ROS (Garcia Fernandez 
et al., 2002). Since the MPT normally opens via various factors, such as the loss of membrane 
potential, with the presence of calcium, it can be assumed that MPT lacks input in Cyt c release, 
since CL distribution change occurs before the loss in potential (Baines et al., 2005). 
1.1.6 Nuclear Estrogen Receptors 
Estrogen receptors are nuclear receptor/transcription factors (Olefsky, 2001). The 
receptors have two subtypes: ERα (discovered in 1958) and ERβ (cloned in 1996; Kuiper et al., 
1996). These two receptors differ in tissue distribution, where ERβ is present in the 
cardiovascular system, ovary, central nervous system, prostate, lung, bone, colon and kidney, 
while ERα is expressed in ovary, testis, uterus, breast, white adipose tissue, bone, liver and heart 
(Jia et al., 2015; Drummond and Fuller, 2010). Because ERβ is distributed more throughout the 
body, it tends to regulate bodily systems and processes, such as the cardiovascular system, 
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inflammation, and reproductive organ development (Drummond and Fuller, 2010; Emmen et al., 
2005). The estrogen receptors also differ in terms of gene loci and molecular weight. ERs are 
normally found in the nucleus, however, they can also be found within the mitochondria (Chen et 
al., 2004); Pedram et al., 2006; Yang et al., 2004) and the cytosol. 
The receptors are composed of five domains, with the N-terminus and C-terminus and 
ligand binding site composing 3 of those domains (Figure 1.4). Even though the two receptors 
are expressed on different chromosomes, and have differences in domain structure (Deroo and 
Buensuceso, 2010.), the ligand binding sites are similar (Pike et al., 1999.). ERα and ERβ 
receptors show similar binding affinities with endogenous and synthetic ligands (Drummond and 
Fuller, 2012; Katzenellenbogen, 1996; Hall and Korach, 2002), although certain ligands favour 
one subtype over another, such as phytoestrogens (Kuiper et al., 1997; Whitten and Naftolin, 
1998) and genistein (Kupier et al., 1997; Whitten and Patisaul, 2001; Martin et al., 2004) 
favoring ERβ over ERα. 
1.1.7 Estrogen Receptors Mechanism of Action 
ERs operate in three known mechanisms of action: ―classical‖ ligand-dependent 
activation, ligand-independent activation and non-genomic activation. For the ligand-dependent 
activation, the unbound ERs, which are present within the cytoplasm, are inactivated by forming 
a complex with a variety of heat shock proteins (Hsp), which has been reviewed in Sanchez, 
2012. Once the ligand binds, the Hsps dissociate and binding with DNA occurs, recruiting co-
regulators, such as steroid receptor coactivators (SRCs) (Xu et al., 2009); the conformation of the 
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receptor towards coactivators and corepressors is affected by the nature of the ligand (Paige et 
al., 1999; Pike et al., 1999). Since ERs are also transcription factors, they influence the 
expression of genes, specifically through binding with the ERE (Estrogen Response Element) 
(Hall and Korach, 2002; Gruber et al., 2004; Hall et al., 2002). Chang et al., 2006 showed 
different genes that were regulated by ERβ specifically, including FOXM1, CDC25A, E2F1 and 
SURVIVIN, SDF-1, THBS1 and BMP-7 genes. Other genes regulated by ERβ include PCNA 
and CDC6 genes (Lobenhofer et al., 2002; Frasor et al., 2003), and CDC2 and CKS2 genes (Lin 
et al., 2007); however, ligand-bound ERs could activate other transcription factors that are not 
related to EREs (see below). For the ligand-dependent activation, the unbound ERs are activated 
via phosphorylation via different kinases, such as MAPK and PI3K (Miller et al., 2011; Riggio et 
al., 2011; McGlynn et al., 2013), Erk and Akt; a review performed by Thomas and Gustafsson, 
 
A B C D E F 
1 595 
ERα 
    
N-Terminal 
Domain 
DNA Binding 
Domain Hinge Domain 
Ligand Binding 
Domain 
180 263 302 
AF-1 AF-2 
 
A B C D E F 
1 530 
ERβ 
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Domain 
DNA Binding 
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Domain 
149 214 248 AF-2 AF-1 
Figure 1.4 Estrogen Receptor Structure 
The figure depicts the structural overview of the estrogen receptors. The top 
structure portrays the ERα and the bottom structure pertains to ERβ. The 
numbers on the structures represent the amino acid sequences, and the domains 
are labeled from A to F; domains A and B form the N-Terminal Domain, and E 
and F form the Ligand Binding Domain. AF: Activation Function 
12 
 
2011 showed the essential role kinases play in the activation of ERα and its association with 
breast cancer. For the non-genomic mechanism, the ligands bind to ERs localized at the plasma 
membranes; this mechanism could justify the rapid effects of E2 treatment (Simoncini et al., 
2004), including increases in ion fluxes across membranes, activation of eNOS (endothelial 
nictric oxide synthase) and kinases (Deroo and Buensuceso, 2010). 
Depending on the situation and the accessibility of the promoter of transcription, the ERs 
will either induce or inhibit gene expression (Ratajczuk, 2001): transcription is activated via 
histone acetyltransferase (HAT), which causes a disruption in the chromatin structure via 
acetylation, and is then continued via RNA polymerase; transcription is inhibited through the 
action of HDACs (Histone deacetylases), which prevent the ERs from reaching the promoter 
(Leitman et al., 2012). The HAT and the HDAC are members of the coregulators, which are 
enzymes that either help in transcription activation (coactivator) or in transcription inhibition 
(corepressor) (Smith and O'Malley, 2004). 
ERs that are bound to ligands could also commonly (Charn et al., 2010; Carrollet al., 
2006) bind to other transcription factors that are not related to the ERE, such as NFκB, and affect 
the transcription of these unrelated elements (Gruber et al., 2004; Leitman et al., 2012). In 
addition to the ligand binding activation of ERs, it has been shown that intracellular signaling 
molecules, through the activation of kinases, could lead to the activation of ERs, without the 
need for any ligand (Weigel and Zhang, 1998). Moreover, it has been shown that ERs might not 
need to bind to EREs to induce a particular response; instead, it has been shown that ligands 
could bind to cytoplasmic ERs, and through the activation of certain processes, such as ion influx 
and efflux, induce a response, which is quicker (Simoncini et al., 2004) than if a ligand moved 
into the nucleus and bonded with the receptor there (Deroo and Buensuceso, 2010); this quick 
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response could be as a result of the ERs localized at the plasma membrane (Levin, 2000; Levin, 
2009; Lösel and Wehling, 2003; Acconcia and Marino, 2011; Fiocchetti et al., 2014; Fiocchetti 
et al., 2015). 
Interestingly, ERβ and ERα seem to have opposing transcriptional activations (Hall and 
McDonnell, 1999; Lindberg et al., 2003; Thomas and Gustfasson, 2011; Bartella et al., 2012), 
and since they differ in localization and distribution, it could be assumed that the effect of 
estrogens, or other ER agonists, depends on the levels of both subtypes. For example, ERα has 
been shown to activate antiapoptotic genes, whereas ERβ favours proapoptotic genes (Acconcia 
and Marino, 2011; Fox et al., 2009; Marino et al., 2006; Thomas and Gustafsson, 2011); this 
contradiction in responses has also been documented within osteosarcoma cells (Monroe et al., 
2003; Stossi et al., 2004). 
Although ERβ is shown to favour apoptosis, it has been shown to also protect the cell from 
apoptosis caused by oxidative stress by preventing Bax and Bad activation, which would lead to 
cytochrome c release and the eventual caspase-3 activation (Liang et al., 2015). 
1.1.8 Estrogens 
Estrogen is classified into estrone (E1), a weak estrogen hormone (Kuhl, 2005), 17β-
estradiol (E2), the most physiologically important estrogen hormone (Ryan, 1982) and estriol 
(E3), another weak estrogen hormone (Kuhl, 2005). Estrogen has a multitude of functions, which 
include cell growth, differentiation, expression of the complex I, complex IV, and complex 
V/ATP synthase in the mitochondria (Rettberg et al., 2014) and cellular oxidative stress (Miro et 
al., 2011; Sastre-Serra et al., 2012; Sastre-Serra et al., 2010; Yao and Brinton, 2012; Simpkins 
and Dykens, 2008; Richardson et al., 2011; Simpkins et al., 2010). Estrogen has been associated 
with the inhibition of apoptosis by sequestering mitochondrial Ca2+ (Nilsen and Brinton, 2003; 
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Sarkar et al., 2008; Brinton, 2008) while decreasing cytoplasmic Ca2+ (Nilsen and Brinton, 
2003; Simpkins et al., 2010). 
1.1.9 Resveratrol 
Resveratrol (RES), a phytoestrogen produced by the stilbene pathway, has been shown to 
confer cytoprotection in a variety of cell lines via a mechanism that requires ERβ (Wang et al., 
2013). In general, many of the cellular effects of RES are quite similar to those of E2 and the 
ERβ-selective agonist DPN. RES has also been shown to confer neuroprotection when 
administered in the diet prior to an ischemic event (Fiocchetti et al., 2014). 
Resveratrol has also been shown to upregulate MnSOD in the mitochondria. This 
upregulation was shown to inhibit cell proliferation and increase cellular threshold to stress in 
different cell lines, especially in SHSY5Y human neuroblastoma cells; knockdown of MnSOD 
expression through iRNA led to effects contrary to the ones mentioned to manifest, due to insult 
from H2O2 and paraquat. The effects of resveratrol were also observed with E2 and DPN, but 
were not observed with propylpyrazole triol (PPT), which is an ERα agonist, indicating that 
these responses are ERβ –mediated (Robb and Stuart, 2011). Moreover, the stilbenes 
pterostilbene and piceid, which are metabolites and structural analogues of resveratrol, have been 
shown to have some of these same effects by activating the same responses (Robb and Stuart, 
2014.). 
1.1.10 Neuroglobin 
Globins are proteins characterized by having an iron-containing heme prosthetic 
group that conveys oxygen binding capabilities. Neuroglobin (Ngb), a monomeric globin protein 
recognized in 2000 (Burmester et al., 2000) and named so due to its expression in nervous tissue, 
as well as endocrine tissues (Burmester et al., 2000; Reuss et al., 2002). Ngb is widely 
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distributed amongst vertebrates, including mice and humans (Burmester et al., 2000), zebrafish, 
rats and pufferfish (Awenius et al., 2001; Zhang et al., 2002). 
Neuroglobin has a molecular weight of 17 kDa, with a three on three globin fold (Figure 
1.5), where each fold is comprised of eight α-helices, and binds to a single heme group (Vallone, 
et al., 2004; Pesce et al., 2003; Vallone et al., 2004). Ngb binds to oxygen reversibly, with its 
ligand binding capabilities being dependent on the hexacoordination (Figure 1.6) of the heme 
iron atom (Trent and Hargrove, 2002; Dewilde et al., 2001; Pesce et al., 2002;  Hamdane et al., 
2003). Ferric Ngb assumes the hexacoordinated haem, where the HisF8 residue is the fifth haem 
ligand, and the HisE7 residue is the sixth haem ligand. Once oxygen binds to Ngb, the HisE7 Fe 
ligand becomes displaced by oxygen; oxygenated Ngb assumes pentacoordinate conformation, to 
which oxygen has a high affinity to (Weiland et al., 2004).   However, due to the competition 
between oxygen and the HisE7 residue over haem group coordination, the Ngb oxygen affinity is 
lower than expected, and is somewhat similar to myoglobin (Burmester et al., 2000; Dewilde et 
al., 2001; Pesce et al., 2002). The coordinate conformation of Ngb differs from those of Mb and 
Hb as both globins bind to their haem groups in their pentacoordinate conformation. The changes 
of Ngb conformation between hexacoordinate and pentacoordinate seem to be regulated post-
translational; an example involves formation of disulphide linkage between Cys46 and Cys55 
due to oxidation (Hamdane et al., 2003). A second example involves hypoxia and ischemia post-
translational modification of Ngb. Jayaraman et al., 2011 identified that the post-translational 
phosphorylation of Ngb could be through two putative motifs (Figure 1.7): two 14-3-3 protein 
binding sites and an ERK docking domain; 14-3-3 protein interactions regulate phosphorylation 
(Wang et al., 2004), phosphorylation stability (Dent et al., 1995; Chiang et al., 2001; Margolis et 
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Figure 1.6 Stereo View of the Hexacoordinate Haem 
The residues HisE7 (distal), HisF8, LeuF4, ValFG2, ValFG4, and PheG5 
(proximal) are depicted. The HisE7 and HisF8 residues assume an orthogonal 
orientation. The image was obtained from Pesce et al., 2003. 
Figure 1.5 Three “Over” Three Globin Fold Structure 
Overview 
The figure depicts the globin fold of Ngb, comprised of 8 α-
helical segments labeled from A to H. The three over three 
fold involves 3 helices B, G and H ―over‖ the 3 helices A, E 
and F. The haem group is ―sandwiched" within the fold. The 
image was obtained from Pesce et al., 2002.  
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al., 2003) and tertiary structures, while the ERK pathway is activated under hypoxic or ischemic 
events (Minet et al., 2000; Saurin et al., 2000). The phosphorylation due to the aforementioned 
sites has been shown to affect the conformation of Ngb and its ligand binding (Jayaraman et al., 
2011). 
Another difference between Ngb and the globin proteins is the amino acid sequence; the 
similarity between them is around 25% of the amino acid sequence (Figure 1.8). Phylogenetic 
studies of the lineage of Ngb showed that vertebrate globins and Ngb differed from one another 
600 million years ago (Hankeln et al., 2005), but also shows that Ngb shares an evolutionary 
origin with invertebrate globins (Burmester et al., 2000; Pesce et al., 2002). 
1.1.11 Neuroglobin Location and Distribution 
Ngb is expressed in the central nervous system (CNS) (Burmester et al., 2000) and 
peripheral nervous system (PNS) (Reuss et al., 2002). These locations were established 
via mRNA in situ hybridization and immunostaining (Reuss et al., 2002; Mammen et al., 2002; 
Sun et al., 2001; Zhang et al., 2002; Wystub et al., 2003; Geuens et al., 2003). Ngb is expressed 
strongly in the retina (Schmidt et al., 2003), specifically in the plexiform layer and 
the photoreceptors, being exclusively in the mitochondria-rich apical part of the inner 
segments (Schmidt et al., 2003), which have a high demand for oxygen. Ngb mRNA and protein 
were located in neuronal perikarya and processes (Reuss et al., 2002; Mammen et al., 2002; Sun 
Figure 1.7 Primary Structure of Ngb with ERK and 14-3-3 Binding Sites 
The residues HisE7 and HisF8 that coordinate the haem group are highlighted in 
yellow, the residues comprising the 14-3-3 binding sites are highlighted in green 
and the pink highlight represents the ERK docking site. The letters in dark 
represent the phosphorylation of PKA and ERK. 
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et al., 2001; Zhang et al., 2002; Wystub et al., 2003; Geuens et al., 2003), cerebral cortex, 
cerebellum, medulla, caudatoputamen, and substantia nigra (Burmester et al., 2000); Ngb levels 
were also detected in the human brain (Jin et al., 2010), hippocampus, thalamus and 
hypothalamus (Wystub et al., 2003.). Moreover, analysis of ischemic brain tissue showed 
upregulation of neuroglobin, indicating the neuroprotective capabilities of neuroglobin in 
ischemia/reperfusion injury (Sun et al., 2001; Sun et al., 2003). Studies have associated Ngb with 
neuroprotection (Szymanski et al., 2008; Chuang et al., 2010; Lin et al., 2008) further, as it has 
been shown that the decrease in Ngb expression is associated with an increase in the incidence of 
Alzheimer‘s disease (Szymanski et al., 2008), which is mainly characterized with 
neurodegeneration. However, there are studies that show Ngb expression is present in non-
neuronal tissues, such as liver cancer cells (Zhang et al., 2013; Fiocchetti et al., 2014), colorectal 
cancer cells (Fiocchetti et al., 2015), breast cancer cells (Fiocchetti et al., 2016). 
Figure 1.8 Primary Structures of the Globins Ngb, Mb and Hb 
The top amino acid sequence represents myoglobin, the second and third amino acid 
sequences represent haemoglobin (α and β respectively) and the bottom line 
represents neuroglobin. The residues HisE7 and HisF8 that coordinate the haem group 
are highlighted in yellow on the Ngb sequence. The residues that come into contact 
with the haem group are italicized, underlined and in bold. 
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Neuroglobin was thought to be a cytoplasmic protein, which was confirmed when the 
transfection of N- and C-terminal gene fusion constructs between neuroglobin and a green 
fluorescent protein into eukaryotic cell did not show that neuroglobin was combined with or 
moving towards any intracellular structures (Hankeln et al., 2004). However, Ngb was later 
found, through immunostaining, to be expressed in the nucleus and mitochondria, in addition to 
the cytoplasm of SK-N-BE cell lines. These locations of neuroglobin (Hundahl et al., 2010; 
Hundahl,  et al., 2011) along with interactions between neuroglobin and proteins within 
the mitochondria  (Haines et al., 2012), have since been shown in other cell lines.  For example, 
Fiocchetti et al. (2016) demonstrated the localization of Ngb in the mitochondria of MCF-7 cells. 
1.1.12 Neuroglobin and Cytochrome c 
The interaction between Ngb and Cyt c involves the formation of a complex between the 
two proteins, followed by an electron exchange (Fago et al., 2006; Bonding et al., 2008). This 
process is enhanced via electrostatic interactions between Ngb and Cyt c, as the former is acidic, 
while the latter is basic, leading to the formation of opposite charges at a neutral pH. In addition 
to differences in charge, it would seem that the residues Lys25 and Lys72 are important in the 
interaction between the two proteins. This is based on findings that have shown an interaction 
between Cyt c and Apaf-1 through the exact same residues (Yu et al., 2001; Abdullaev et al., 
2002; Ellerby et al., 2000; Chertkova et al., 2008), which will lead to the apoptosome that 
activates the caspase cascade. It is interesting to note that Ngb cannot affect the apoptosome 
formation between Cyt c and Apaf-1, but instead undergoes a redox reaction that causes Cyt c to 
lose its activity (Raychaudhuri et al., 2010). This reaction ceases the formation of the 
apoptosome, successfully leading to the inactivation of caspase 9 (Brittain et al., 2010.; 
Raychaudhuri et al., 2010).This redox reaction involves ferrous Ngb binding with ferric 
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cytochrome c, which is the active form, reducing it to ferrous, which is the inactive form (Suto et 
al., 2005; Borutaite and Brown, 2007; Brown and Borutaite, 2008), oxidizing Ngb from ferrous 
form to ferric form. 
1.1.13 Neuroglobin Upregulation 
Since Ngb has oxygen binding capabilities, it would seem to have a role in ischemia and 
hypoxia (Kelsen et al., 2008; Wang et al., 2008.; Dong et al., 2010.). During hypoxia, it was 
shown that Ngb expression is induced (Yu et al., 2009.) as it is responsible for regulating 
apoptotic signals caused by hypoxia (Hota et al., 2012; Brittain et al., 2010; Brittain and 
Skommer, 2012.). Ngb has been shown to be upregulated during hypoxia in vitro for protection 
(Fordel et al., 2004; Sun et al., 2001). Ngb overexpression in cell cultures derived from 
hippocampal neurons was shown to protect the cells from hypoxic insult, an effect that was 
reversed in Ngb knockdown (Sun et al., 2001). Another study performed on mouse cortical 
neuron cultures with Ngb overexpression has shown neuronal protection againts hypoxic insults 
(Liu et al., 2009). It seems that hypoxia does not upregulate Ngb levels in vivo (Fordel et al., 
2004b; Mammen et al., 2002; Sun et al., 2003). Interestingly, HIF-1 (hypoxia-inducible factor-1) 
expression during hypoxia was shown to regulate Ngb expression (Haines et al., 2012). As for 
ischemia, it was observed that there was an increase in Ngb expression in patients with strokes 
(Jin et al., 2010.). An in vivo study showed that overexpression of Ngb in transgenic mice 
protected them from myocardial and cerebral ischemia in comparison with wild-type mice (Khan 
et al., 2006), and a later study confirmed cerebral ischemic insult amelioration by Ngb 
overexpression in transgenic mice (Wang et al., 2008). In Ngb-null mice, it was shown that 
infarct sizes increase after ischemic insults (Raida et al., 2012), furthering Ngb‘s role in 
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neuroprotection. Other studies showed the effect of Ngb on an insult similar to hypoxic/ischemic 
insult – oxygen glucose deprivation (OGD). 
OGD affects Ngb as well, as evidence showed the expression of certain hypoxia-response 
genes occurs during OGD as a result of Ngb (Yu et al., 2009). Ngb transcript levels as well as 
protein levels have been shown to be upregulated during ODG (Fordel et al., 2007). Furthermore, 
Ngb overexpression in mouse cortical neuron cultures was able to ameliorate neuronal death 
when OGD was imposed; in contrast, Ngb knockdown showed the opposite during OGD insult 
(Yu et al., 2013). And even though Ngb has been shown to be localized within the mitochondria, 
its localization seemingly increases within the mitochondria after OGD occurs (Yu et al., 2012). 
1.1.13.1 Mechanisms of Neuroglobin Regulation 
In addition to oxidative stress, Ngb expression (De Marinis et al., 2010) is also 
upregulated greatly by E2 via ERβ. E2 stimulation has been shown to upregulate Ngb expression 
by approximately 300%, translocate Ngb into the mitochondria and overall, exert an 
antiapoptotic effect through the upregulation of Ngb (De Marinis et al., 2010; De Marinis et al., 
2013; Fiocchetti et al., 2013). The effect of E2 on Ngb levels appears to be dependent on the 
dosage and the time of treatment in MCF-7 and HepG2 cells (Fiocchetti et al., 2014) and DLD-1 
cells (Fiocchetti et al., 2015). 10 nM E2 seems to induce the highest Ngb expression, which 
peaks between 4 and 6 hours following the onset of treatment followed by a gradual decrease for 
up to 24 hours in the MCF-7 and HepG2 cells (Fiocchetti et al., 2014), while the levels remained 
constant from 4 to 24 hours  for DLD-1 cells (Fiocchetti et al., 2015). As Ngb upregulation is 
dependent on E2 via ERβ, and since ERβ acts as a transcription factor, the transcriptional 
modulation of Ngb proves insightful. The transcriptional modulation of Ngb upregulation was 
studied via the application of actinomycin D (Act), a transcription inhibitor, and the modulation 
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of E2-dependent Ngb upregulation was studied via 2-bromohexadecanoid acid (2-Br), a 
palmitoyl acyltransferase (PAT) inhibitor that inhibits the cell membrane localization of ERs 
(Acconcia and Marino, 2011; Marino et al., 2006). The impairment of Ngb upregulation with E2 
stimulation by actinomycin D shows that E2-dependent upregulation of Ngb is modulated 
transcriptionally in MCF-7, HepG2 (Fiocchetti et al., 2014) and DLD-1 cells (Fiocchetti et al., 
2015). The upregulation of Ngb with E2 stimulation by 2-bromohexadecanoid acid also shows 
that the modulation of E2-dependent Ngb upregulation depends on signaling pathways that begin 
with the plasma membrane in MCF-7, HepG2 (Fiocchetti et al., 2014) and DLD-1 cells 
(Fiocchetti et al., 2015). A more specific look at the signaling pathways revealed the role kinases 
play in E2-dependent Ngb upregulation. 
Studies showed that around 10 minutes of 10 nM E2 treatment increased the 
phosphorylation of p38/MAPK, AKT and ERK (Acconcia et al., 2005; Galluzzo et al., 2007), 
which are present in the transduction cascades of ER signaling pathways (Acconcia and Marino 
2011). After 24 hours of E2 stimulation, the Ngb upregulation was prevented by AKT and ERK 
inhibitors in MCF-7 (Fiocchetti et al., 2014) and was prevented by p38 inhibitors in HepG2 
(Fiocchetti et al., 2014) and DLD-1 cells (Fiocchetti et al., 2015), confirming the role p38 plays 
in the upregulation of Ngb (Caiazza et al., 2007; Galluzzo et al., 2007), which might suggest 
cell-line specific kinase activity with respect to E2-dependent Ngb upregulation. 
For mRNA levels, it was shown that 4 hours of E2 treatment showed peak mRNA 
transcript levels in the MCF-7 and HepG2 cells (Fiocchetti et al., 2014) but remains fairly 
constant between 4 and 24 hours in DLD-1 cells (Fiocchetti et al., 2015); this suggests that E2 
could prevent Ngb degradation post-transcriptionally. The post-transcriptional prevention of Ngb 
degradation was tested via chloroquine, an inhibitor of lysosomal enzymes by altering the pH of 
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lysosomes and endosomes (Totta et al., 2014), and Mg-132, a 26S proteasome-mediated 
degradation inhibitor (Totta et al., 2014). The increase in the levels of Ngb in the presence of the 
inhibitors (Fiocchetti et al., 2015) would suggest that Ngb is degraded via lyososomes and 
proteasomes. 
Even though E2 induces the translocation of Ngb into the mitochondria in neuronal cells 
(De Marinis et al., 2013), it was shown that E2 affects Ngb translocation in non-neuronal cells. 
24 hours of 10 nM E2 stimulation was shown to increase Ngb localization in the mitochondrial 
subcellular compartment in MCF-7 and HepG2 cells (Fiocchetti et al., 2014) and DLD-1 
(Fiocchetti et al., 2015); Ngb localization decreased in the nuclear compartment alongside the 
mitochondrial increase in all the cell lines. Interestingly, Ngb localization was shown to increase 
in the cytoplasm within HepG2 cells (Fiocchetti et al., 2014) and DLD-1 cells (Fiocchetti et al., 
2015), but not for MCF-7 cells (Fiocchetti et al., 2014). As E2 stimulation is required for Ngb 
translocation, it is also important to note that E2-dependent Ngb upregulation prevents the 
deleterious effects of oxidative stress. 
E2-dependent Ngb upregulation within neuronal cells is pivotal to reducing the effects of 
oxidative stress (De Marinis et al., 2013; Fiocchetti et al., 2013). Hydrogen peroxide treatment of 
MCF-7 cells (Fiocchetti et al., 20145) and DLD-1 cells (Fiocchetti et al., 2015) triggered the 
apoptotic pathway, but the pretreatment with E2 prevented apoptosis. It was shown that E2 
treatment with hydrogen peroxide upregulated Ngb levels; in Ngb-silenced MCF-7 cells 
(Fiocchetti et al., 2014) and DLD-1 cells (Fiocchetti et al., 2015), E2 treatment was unable to 
prevent the apoptosis triggered by hydrogen peroxide. This suggests that the E2-dependent Ngb 
upregulation is important to counteract the detrimental effects of hydrogen peroxide. 
1.1.14 Neuroglobin Translocation into Mitochondria 
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Proteins that are normally imported (Figure 1.8) into the mitochondria are of two 
different classes: proteins that carry the N-terminus targeting sequence with cleavable extensions 
or proteins that carry internal signals without cleavable extensions (Pfanner and Geissler, 2001; 
Truscott et al., 2003; Chacinska et al., 2009). In case of the former, the N-terminus targeting 
sequence is recognized by TOM (translocase of outer membrane). Once the recognition is 
complete, the protein becomes imported into the mitochondria to serve its destined purpose 
(Schatz and Dobberstein, 1996). The lack of mitochondrial targeting sequence within the Ngb 
structure still does not justify the localization of Ngb. An explanation to the localization of Ngb 
without the N-terminus presequence is that the mitochondrial targeting sequence is not highly 
conserved (Truscott et al., 2003), which would mean that Ngb has a unique targeting sequence. 
Another justification is that mRNA and ribosomes are recognized (Marc et al., 2002; Riemer et 
al., 2011), which would mean that the import of Ngb could be possible through co-translational 
transport. 
The translocation of Ngb into the mitochondria might also be related to the VDAC and 
MPT, as a study that used inhibitors of VDAC and MPT yielded a reduction in the increased Ngb 
translocation into the mitochondria that is expected during OGD (Yu et al., 2012). The 
translocation of Ngb into the mitochondria would indicate that the expression of Ngb takes place 
in the nuclear DNA (Burmester et al., 2000). Evidence of the translocation of Ngb from the 
cytoplasm into the mitochondria has been elucidated by the interaction of Ngb with multiple 
proteins within the mitochondria, such as Etfa (Electron-transfer flavoprotein) (Yu et al., 2012), 
Cyc1 (a subunit of the third respiratory complex) and VDAC (Zhu et al., 2011). However, the 
exact mechanism of mitochondrial importing of Ngb is not well known. 
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1.1.15 Insights into Ngb Function via Overexpression and Knockdown 
Ngb overexpression has been associated with reduction in brain injury caused by 
intracerebral hemorrhage (Jin et al., 2011.), which would further confirm Ngb‘s role in 
neuroprotection. An in vivo study using exogenous Ngb demonstrated that it could be taken up 
by the neurons of the mice used, and even protects the brain from ischemic injury (Cai et al., 
Figure 1.9 Protein Import into Mitochondrion 
The complexes TOM, TIM23 and TIM22 are responsible for importing 
proteins destined to the internal compartments, while the Export complex 
is responsible for exporting proteins from the matrix and into the inner 
membrane. The specific receptor (R) is the site of binding for proteins 
with the N-terminal sequence or internal signals, which then directs the 
protein through the general import pore (GIP) of the translocase of the 
outer membrane (TOM). The proteins with the N-terminal presequence 
are imported across the inner membrane via the TIM23 complex and into 
the matrix. The proteins with the internal targeting sequences are destined 
for the inner membrane, and are directed by the Tim factors to the TIM22. 
Membrane insertion at the TIM22 complex is dependent on the membrane 
potential. The export complex export proteins that are encoded in the 
mitochondria and some imported proteins to the inner membrane. IM: 
inner membrane; IMS: intermembrane space; OM: outer membrane. The 
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2011.). Furthermore, overexpression of Ngb, through a transfection of the SH-SY5Y cells, 
protected the cells against H2O2 injury (Antao et al., 2010.). Moreover, Ngb overexpression in 
SH-SY5Y cells and cortical neurons of transgenic mice lead to a decrease in calcium levels, 
maintaining the integrity of the mitochondrial membrane and its potential in the process (Duong 
et al., 2009; Liu, et al., 2009). In addition, Ngb overexpression has been shown to defend against 
cell death that has been caused by OGD, H2O2, paraquat and amyloid beta peptide (Sun et al., 
2001; Fordel et al., 2006; Li et al., 2008; Li et al., 2008; Raychaudhuri et al., 2010; Antao et al., 
2010). To further determine the protective measures of Ngb, Ngb overexpression was 
implemented in transgenic mice in a study by Li et al., 2010; the results showed that the 
production of RNS and ROS, as well as the peroxidation of lipids, decreased in neurons, hinting 
at an association between Ngb and its antiapoptotic activities (Li et al., 2010.).  Even though the 
in vivo protective role of Ngb is contradictory to the in vitro studies (Hundahl et al., 2006), there 
have been in vivo studies that show that Ngb overexpression in transgenic animals was 
associated with a reduction in cerebral infarct size (Khan et al., 2006; Wang et al., 2008). 
As for knockdowns, in vitro studies regarding the knockdown of Ngb has been associated 
with a decrease in neuroblastoma cell viability under oxidative stress (Ye et al., 2009) and an 
increase in cortical neuronal death as a result of hypoxia (Szymanski et al., 2008). Sun et al., 
2003 administred an adeno-associated viral vector that would express Ngb into the cerebrum of 
rats that underwent Ngb knockdown, and it was observed that the size of the infarct was reduced 
as well (Sun et al., 2003). 
1.1.16 Neuroglobin Mechanism of Action 
Other than its interaction with Cyt c, evidence indicates that Ngb interacts with the G-
proteins (Wakasugi et al., 2003); the ferric form of Ngb was shown to bind to the G𝛼 subunit in 
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the GDP-bound state, where it acts as a GDI (guanine-nucleotide dissociation inhibitor) 
(Wakasugi et al., 2003.). This action inhibits the conversion of GDP to GTP, which prevents the 
G𝛼 subunit from binding to the G𝛽𝛾 complex, causing the release of the Gβγ subunit (Wakasugi 
et al., 2003; Schwindinger and Robishaw, 2001). This in turn activates the neuroprotective effect 
of NGF (nerve growth factor), which works through the activation of the PI3K/Akt pathway 
(Dudek et al., 1997.). To confirm that Gβγ is required for the neuroprotective effect to occur, Wu 
and Wong, 2006 demonstrated that the Gβγ inhibitor, transducin, prevented the neuroprotective 
effect of NGF, which in turn confirms the role of PI3K/Akt pathway involvement (Wu and 
Wong, 2006). Hypoxia and ischemia induce HIF-1α, which in turn, induces insulin growth 
factor, which activates the PI3K/Akt pathway (Li et al., 2006.). Since HIF-1α affects Ngb 
expression (Haines et al., 2012.), it might be a valid connection between Ngb and its effect 
through the PI3K/Akt pathway, which favours cell survival (Jover-Mengual et al., 2010). 
Hemin, a porphyrin, has been shown to upregulate Ngb mRNA and pAkt levels, indicating that 
there could be a connection between Ngb and pAkt (Zhang et al., 2013). Another study that 
shows the association between Ngb and Akt observed that Ngb protected cells against H2O2 
injury by phosphorylating Akt and activating the mito-KATP channel (Antao et al., 2010.); pAkt 
(phosphorylated Akt) inhibits apoptosis by preventing the release of Cyt c and AIF from the 
mitochondria (Tapodi et al., 2005). 
There is an increase in the activity of nNOS after ischemia (Lipton, 1999), which will 
eventually lead to cell death, as the continuously produced NO will induce mitochondrial 
permeabilization, which will then lead to the release of Cyt c and the eventual activation of the 
caspase cascade (Zhu et al., 2004). Since the ferric and ferrous forms of Ngb show reactive 
potential with nitrogen in vitro, the neuroprotective mechanisms of Ngb could lie within NO 
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(even though it is not as significant as Hb or Mb (Smagghe et al., 2008)) and RNS scavenging; 
the latter has been observed within reactions between Ngb and the nitrite and peroxynitrite 
anions (Zhu et al., 2004), which does not require a ferryl intermediate (Herold et al., 2004). 
The ferrous form of Ngb is important due to its NO scavenging capabilities (Brunori et al., 
2005), which would indicate that the continuous reduction and oxidation of Ngb is important. 
The protective function of Ngb could also be related to its scavenging abilities for peroxynitrite 
anion (ONOO−) (Fago et al., 2004a), which constitutes RNS, as well scavenging for ROS, 
during hypoxia (Fordel et al., 2007). It could also be attributed to nitric oxide homeostasis 
(Brunori et al., 2005; Brunori and Vallone, 2006) and acting as a sensor for hypoxia (Wakasugi 
and Morishima, 2005) in neurons. The management of the reactive species may not be a result of 
a direct interaction between Ngb and the reactive species however, as it could also be due to an 
interaction between Ngb and the respiratory complexes, which was observed in the works of Yu 
et al., 2012 and Yu et al., 2012 (Yu et al., 2012; Yu et al., 2012.). The direct effect of Ngb on 
reactive species has been documented however, in a study by Li et al., 2011; recombinant human 
Ngb has been shown to directly scavenge reactive species effectively, including hydrogen 
peroxide, superoxide anion and hydroxyl radicals (Li et al., 2011). The scavenging capabilities of 
the recombinant human Ngb were lesser than vitamin C, but were greater than GSH (Li et al., 
2011.). 
The ferric Ngb has been shown to inhibit the GPCR (G-protein coupled receptor) 
(Wakasugi et al., 2003), which is required for the formation of IP3 from PIP2. IP3 is required for 
the release of calcium from the endoplasmic reticulum when bound to the IP3 receptor, which 
will lead to an increase in the release of calcium. Thus, the inhibition of IP3 production by Ngb 
will lead to a decrease in calcium levels within the cytoplasm, which agrees with the findings 
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that showed Ngb colocalizing with orexin, an excitatory neuropeptide that increases calcium 
levels within neurons, as well as amyloid beta, and lead to the eventual death of the cell, hinting 
further at the neuroprotective capabilities of Ngb. 
Another protective mechanism for Ngb involves the inhibition of Pak1 kinase and the 
interaction with members of the RhoGTPase family; this mechanism induces reorganization in 
the cytoskeleton and prevents the aggregation of mitochondria at the lipid raft, preventing any 
hypoxia-induced death signaling (Khan et al., 2008). This mechanism has also been shown in 
death signaling induced by NMDA excitatoxicity and amyloid beta in neurons as well (Khan et 
al., 2007). 
1.2 Objectives 
1.2.1 To determine if Ngb inhibits apoptosis via the inhibition of cytochrome c peroxidase 
activity. 
1.2.2 To determine if the phytoestrogen resveratrol (RES), like estradiol (E2) stimulates Ngb 
expression and affects Ngb subcellular localization. 
1.2.3 To determine if Ngb stabilizes mitochondrial network stability under physiological stress. 
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Chapter 2.0: The effect of Ngb on cytochrome c peroxidase activity 
2.1 Introduction 
Cyt c is part of the cytochrome c family haemproteins, and seems to be normally 
localized within the intermembrane space of the mitochondrion (Neupert 1997), particularly at 
the inner membrane portion. It is part of the electron transport chain (ETC), where it transfers 
electrons from Complex III (Coenzyme Q – Cyt C reductase or cytochrome bc1 complex) to 
Complex IV (Cyt C oxidase). The 12 kDA protein contains a haem group that binds to the two 
cysteine side chains via thioether bonds (Kang and Carey, 1999). The ability of the haem group 
to be reduced grants cytochrome c multiple functions, which affects the kinetics of electron 
transfer (Zhao et al., 2003); this haem group accepts the electron from Complex III and transfers 
it to Complex IV. In addition to its function in the ETC, cyt c plays a role in apoptosis, 
particularly the intrinsic apoptotic pathway, with the peroxidation of the lipid of the inner 
mitochondrial membrane – cardiolipin.  
Cardiolipin is a type of diphosphatidylglycerol lipid that compromises the inner 
membrane of a mitochondrion. As it is the main component of the inner mitochondrial 
membrane, the functions of cardiolipin involve proteins integrated in that membrane. It has been 
shown that cardiolipin is associated with maintaining the quaternary structure of Complex III as 
well as the function of the enzyme (Gomez and Robinson, 1999). Also, it seems that ATP 
synthase has a high-binding affinity to cardiolipin (Eble et al., 1990) and that function of 
Complex IV is maintained via cardiolipin. In addition to the role that cardiolipin plays in the 
structure and function of the inner membrane, the lipid seems to play a role in apoptosis as well; 
the peroxidation of cardiolipin causes the release of the pro-apoptotic protein – cytochrome c. 
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When cyt c interacts with cardiolipin at the inner mitochondrial membrane, the haem 
group becomes exposed to hydrogen peroxide (H2O2), which is produced during the electron 
transport; the hydrogen peroxide binds to the haem group, which activates the intrinsic 
peroxidase activity of cyt  c (Kagan et al., 2005; Gonzalvez and Gottlieb, 2007; Ott et al., 2007). 
Cardiolipin becomes oxidized from the peroxidase activity, and forms cardiolipin 
hydroperoxides that have a different structural conformity; the oxidized cardiolipin becomes 
distributed at the outer mitochondrial membrane, creating pores that aid in the release of cyt c 
(Orrenius and Zhivotovsky, 2005; Paradies et al., 2009). The release of cyt c from the 
intermembrane space to the cytoplasm triggers the intrinsic apoptotic pathway. A role of cyt c in 
apoptosis is that it binds to the IP3 receptor on the endoplasmic reticulum, which leads to the 
release of calcium. Calcium then enters the mitochondria and induces swelling and eventual 
fragmentation of the mitochondria, which creates an increase in cyt c release in a positive 
feedback mechanism (Boehning et al., 2003). The other role of cyt c is to create the apoptosome 
(a multimolecualr holoenzymatic complex) that cleaves and activates procaspase 9, which leads 
to the formation of caspase 9 and the eventual activation of the caspase cascade (Kroemer et al., 
1998). 
Ngb seems to have an anti-apoptotic effect, possibly due to the interaction with cyt c 
(Brittain et al., 2010; Yu et al., 2012). The active form of cyt c that leads to the activation of the 
intrinsic apoptotic pathway is the ferric cyt c form (Brittain et al., 2010; Ascenzi et al., 2011). It 
has been shown that Ngb reduces ferric cyt c to ferrous cyt c, which inhibits the apoptotic 
activity of cyt c (Suto et al., 2005; Borutaite and Brown, 2007; Brown and Borutaite, 2008; 
Raychaudhuri et al., 2010). The interaction between Ngb and cyt c was thought to occur 
exclusively within the cytoplasm (Brittain and Skommer, 2012). However, studies have shown 
32 
 
that Ngb translocates to mitochondria under some conditions. It has been shown that Ngb 
translocation to the mitochondria occurs via the mPTP, which is located on the inner 
mitochondrial membrane, and VDAC, which is located on the outer mitochondrial membrane 
(Yu et al., 2012). De Marinis et al., 2013 also showed that there is an association between cyt c 
and Ngb within the mitochondria. The interaction with cyt c within the mitochondria could be 
putatively associated with Ngb‘s ability to reduce cyt c; the role of Ngb in inhibiting apoptosis 
by interacting with cyt c within the mitochondria has not been fully elucidated. 
The evidence shows that Ngb interacts with cyt c and is able to translocate into the 
mitochondria to prevent cyt c release. Since Ngb is able to prevent the release of cyt c from the 
mitochondria, it could be hypothesized that Ngb could have an effect on the intrinsic peroxidase 
activity of cyt c.  
In order to assess the effect of Ngb on the intrinsic peroxidase of cyt c on cardiolipin, the cyt 
c peroxidase activity assay was undertaken. The assay involves the use of Amplex Red reagent 
(as described in Atkinson et al., 2011 and Birk et al., 2013) using the Varian Cary Eclipse 
fluorescence spectrophotometer equipped with the microplate reader (obtained from Agilent 
Technologies, Santa Clara, CA, USA). The assay involves the formation of resorufin from the 
oxidation of the Amplex Red alongside the activation of the cyt c peroxidase intrinsic activity 
(Zhou et al., 1997).  
2.2 Materials and Methods 
2.2.1 Materials 
   Cytochrome c from bovine heart (Catalogue# C3131), cardiolipin (from bovine heart) in 
ethanol (Catalogue# C1649) and 9.79 M hydrogen peroxide (Catalogue# 216763) were obtained 
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from Sigma-Aldrich (St. Louis, MO, USA) HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) and DMSO (Dimethylsulfoxide) were obtained from BioShop 
(Burlington, ON, Canada). 
   Amplex Red (10-Acetyl-3,7-dihydroxyphenoxazine) was obtained from Cayman Chemical 
(Ann Arbor, MI, USA). 
   Purified Recombinant Human Neuroglobin (Catalogue# ab63278) was obtained from Abcam 
(Cambridge, UK). 
2.2.2 Methods 
2.2.2.1 Cytochrome c peroxidase activity assay 
The intrinsic activity of cyt c was measured with purified cyt c, purified cardiolipin and 
the reagent Amplex Red as mentioned above. The spectrophotometer measures the fluorescence 
from resorufin, which is formed as a result of the oxidation of Amplex Red during the activity of 
cyt c peroxidase. The assay involves the usage of cyt c (1 µM; from bovine heart) was incubated 
with cardiolipin (15 µM; ≥80% polyunsaturated fatty acid content, primarily linoleic acid, from 
bovine heart) in HEPES buffer (20 mM, pH 7.4) with or without purified Ngb for 20 minutes. 
H2O2 and Amplex Red (both at the final concentration of 50 µM) were then added to initiate the 
activity, with the resorufin formation rate being measured over 10 minutes using excitation of 
525 nm and emission wavelengths of 590 nm. Maximal reaction rates (measured in Arbitrary 
Fluorescence Units (AFU) per minute) were calculated from the initial linear range of the 
formation of resorufin using Cary Eclipse Kinetics softaware (obtained from Walnut Creek, 
USA). The entirety of the assay was performed at room temperature, protected from light.   
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2.3 Results 
2.3.1  Neuroglobin does not inhibit cytochrome c peroxidase activity 
   The intrinsic cardiolipin peroxidase activity of cyt c was measured with cyt c alone as 
well as cyt c with cardiolipin using an Amplex Red/horseradish peroxidase-based fluorometric 
assay (Fig. 2.1), with the latter condition mimicing the normal peroxidation process; the linearity 
of the fluorescence change measured till 10 minutes. The change in fluorescence witth cyt c 
alone was 2.5 times less than the measurement for cyt c with cardiolipin and was significantly 
different (p-value ≤ 0.001). The fluorescence measurement of the reaction with the presence of 
cardiolipin and Ngb alongside cyt c and cardiolipin was around 7.6 Fluorescence Arbitrary 
Units, which is around 2.4 times greater than the measurement with the presence of cytochrome 
c alone. However, the measurement with presence of cardiolipin alongside cyt c was not 
statistically significant (p-value = 0.24). 
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2.4 Discussion 
2.4.1 Neuroglobin lacks inhibitory effect on cytochrome c peroxidase activity 
   The lack of increase in the fluorescent measurement in the presence of cyt c alone relative to 
the measurement in the presence of cyt c and cardiolipin, was expected, as the peroxidase 
activity of cyt c is largely activated when cyt c interacts with cardiolipin; the exposure of the 
haem group within cyt c towards H2O2 would activate the peroxidase activity. The increase in 
fluorescence after the addition of cardiolipin agrees with multiple authors (Figure 2.2) (Petrosillo 
et al., 2001; Kagan et al., 2005), since cardiolipin exposes the haem group of cyt c during their 
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Figure 2.1: Neuroglobin does not inhibit Cytochrome c Peroxidase Activity    
The bar chart shows the three different experimental conditions: cytochrome c 
alone (negative control), cytochrome c with cardiolipin (positive control) and 
cytochrome c with cardiolipin and neuroglobin. The bars represent means ± SEM 
from triplicates for each condition. The statistical analysis between the positive 
control (a1) and the experimental condition (a2) were analyzed with the 
independent T-test (p-value = 0.24). ** indicates a p-value less than 0.001. 
** 
b 
a1 a2 
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interaction, allowing H2O2 to react with the haem group; the activation of the peroxidase activity 
of cyt c correlates with the increase in the fluorescence of the assay. 
       However, the non-significant difference between the measurement of the fluorescence after 
the addition of Ngb and the measurement with cardiolipin and cyt c only could show that Ngb 
does not interact with cyt c through the inhibition of the intrinsic peroxidase activity. This lack of 
inhibition could be because the ratio of Ngb to cyt c used was 1:1, where there is evidence that 
the anti-apoptotic effects occur when the ratio of Ngb to cyt c is 3:1 (Raychaudhuri et al., 2010). 
Another explanation could be due to the differences in localization of cyt c and Ngb. 
     
 
 
 
 
 
 
 
 
    
Figure 2.2 H2O2-Induced oxidation 
chemiluminescence response 
The figure depicts the oxidation of luminol via 
H2O2 in a manner similar to the Amplex Red 
reagent. The red curve shows cyt c with 
cardiolipin, while the black dotted curve shows 
cyt c without cardiolipin. The figure was obtained 
from Kagan et al., 2005. 
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      Cyt c is exclusively localized in the intermembrane space of the mitochondria, where it 
peroxidizes the cardiolipin at the inner membrane, leading to the release of cyt c. Even though 
Ngb localizes in the mitochondria, its exact location has not been elucidated. Lechauve et al., 
2012 has shown that Ngb localizes within the mitochondrial matrix, which was confirmed when 
Ngb presence was detected in mitoplasts (mitochondrion devoid of the outer membrane and the 
intermembrane space). This location would explain the lack of any Ngb inhibitory activity 
towards the cyt c peroxidase activity; a putative ratiocination is that Ngb is unable to reach cyt c 
and interact with it in the intermembrane space, as the inner membrane acts as a barrier. 
However, the lack of interaction between the two proteins contradicts results from certain 
authors (De Marinis et al., 2013). Another putative explanation is that Ngb does not affect cyt c‘s 
peroxidase activity as it acts as a scavenger for ROS (Herold et al., 2004; Fordel et al., 2007) 
within the matrix, which means that it will not interfere with the reaction between H2O2 and the 
haem group of cyt c.  
        A third supposed deduction could be that Ngb binding with cyt c requires the ferric form of 
cyt c, which is required for the apoptosome to form (Pan et al., 1999; Suto et al., 2005). This 
would suggest that the interaction between Ngb and cyt c is possible upon the release of the cyt c 
into the cytoplasm. That interaction contrasts with the evidence that shows that Ngb and cyt c 
interact together within the mitochondria (De Marinis, 2013). It would be safe to assume that the 
Ngb role within the mitochondria would be the scavenging of ROS and RNS. 
2.5 Conclusion 
Given the data provided, Ngb does not inhibit the peroxidase activity of cyt c in a 1:1 ratio as 
there was no significant difference between the fluorescence measurement in the cyt c and 
cardiolipin group and the cyt c, cardiolipin and Ngb group. 
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Chapter 3.0: The Effect of E2 and RES on Ngb expression and subcellular localization 
3.1 Introduction 
Ngb has been shown to be cytoplasmic (Reuss et al., 2002; Zhang et al., 2002; Schmidt et 
al., 2003; Wystub et al., 2003) via evaluations of bioinformatical sequences (Schmidt et al., 
2004), which involves predictive systems to predict localization such as SCLpred (Mooney et al., 
2011), and has been shown to translocate and localize in the mitochondria (Bentmann et al., 
2005), where it is thought to prevent the release of cyt c and the eventual activation of apoptosis. 
This mechanism is the hypothesized role of Ngb in promoting cell survival. Literature has been 
shown that the role of Ngb is dependent on its upregulation via E2 stimulation. 
   Transcriptioanl upregulation of Ngb (via ERβ) has been shown to reach approximately 300% 
in SK-N-BE neuroblastoma cells, mouse hippocampal neurons and mouse astrocytes (De 
Marinis et al., 2010; Marinis et al., 2013). The release of cyt c from the mitochondria was 
prevented as a result of E2-dependent Ngb upregulation, leading and to its translocation into the 
mitochondria and preventing the cyt c release (De Marinis et al., 2010; Fiocchetti et al., 2012; De 
Marinis et al., 2013; Fiocchetti et al., 2013). Recent studies have also shown that Ngb 
translocates into the mitochondria in MCF-7 (breast cancer cells) (Fiocchetti et al., 2014), 
HepG2 (liver cancer cells) (Fiocchetti et al., 2014) and DLD-1 (colorectal cells) (Fiocchetti et al., 
2015). The upregulation of Ngb does not only occur in nervous cells (such as SK-N-BE and SH-
SY5Y cells), but there is evidence that elucidates the E2-dependent Ngb upregulation in non-
neuronal cells, including MCF-7 (Fiocchetti et al., 2014), HepG2 (Fiocchetti et al., 2014) and 
DLD-1 (Fiocchetti et al., 2015); the upregulation was both time-dependent and dose-dependent 
these cells (Fiocchetti et al., 2014; Fiocchettis et al., 2015). Since ERs have a transcriptional and 
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non-genomic activity (Ascenzi et al., 2006; Marino et al., 2006; Acconcia and Marino, 2011), the 
effect of E2 stimulation on Ngb mRNA transcript levels and protein levels were elucidated.  
   Fiocchetti et al., 2014 elucidated the effect of 10 nM E2 stimulation across different time 
points on HepG2 and MCF-7 cells; it was shown that E2 has upregulated the Ngb mRNA 
transcripts, with a significant increase peaking at 4 hours of E2 treatment, then decreasing and 
after that till 24 hours. In another study, 10 nM E2 stimulation across different time points in the 
DLD-1 cells showed that there was no significant effect on the Ngb mRNA transcript (Fiocchetti 
et al., 2015). In addition to measuring mRNA expression levels, studies show the effect of the 
transcription inhibitor actinomycin D (Act) on the E2-dependent Ngb upregulation. It was shown 
that E2-dependent Ngb upregulation was inhibited as a result of Act (Fiocchetti et al., 2014), 
which would confirm that Ngb upregulation is transcriptionally modulated. Intriguingly, Act did 
not inhibit the E2-dependent Ngb upregulation, but rather reduced the upregulation signicantly.  
   In order to assess the effect of RES on the upregulation of Ngb protein levels, western blots 
were undertaken for SH-SY5Y cells. The detection of Ngb protein levels after E2 stimulation via 
western blots, were used as a positive control. Ngb mRNA levels were detected via quantitative 
real-time PCR after E2 stimulation; Ngb mRNA levels in SH-SY5Y cells were first detected in 
hypoxic and OGD conditions as a positive control to validate the PCR technique. To assess 
subcellular localization of Ngb, a fusion protein of Ngb and GFP (Green Fluorescent Protein) 
was created using Gibson Assembly between a GFP-containing plasmid (mEmerald mito-7) and 
Ngb-containing plasmid (pCMV3-GFPSpark-Ngb).  
3.2 Materials and Methods 
3.2.1 Materials 
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   PVDF (Polyvinylidene fluoride) 0.45 µm membrane (Catalogue# 1620112), Microseal ‗B‘ 
Adhesive Seals (Catalogue# MSB1001), Multiplate Low Profile 96-Well Unskirted PCR Plates 
(Catalogue# MLL9601), iScript cDNA Synthesis Kit (Catalogue# 170-8891), SsoAdvanced 
Universal SYBR Green Supermix (Catalogue# 172-5270) and thick filter paper (Catalogue# 
1703969) were obtained from Bio-rad (Mississauga, ON, Canada). 
   Charcoal-stripped fetal bovine Serum (Catalogue# 080-750) was obtained from Wisent, Inc. 
(Saint-Jean-Baptiste, QC, Canada).  
   Supplement-free Dulbecco‘s Modified Eagle Medium powdered media (Catalogue# 5030),  
Dulbecco‘s Modified Eagle Phenol Red-Free Medium (Catalogue# D1145), Dulbecco‘s 
Modified Eagle Medium (Catalogue# D6429), L-glutamine, sodium pyruvate (Catalogue# 
D7777, nonessential amino acids, fetal bovine serum (Catalogue# F6178), 
penicillin/streptomycin solution and 0.25% trypsin/EDTA solution were obtained from Sigma-
Aldrich (St. Louis, MO, USA). 
   10 cm cell culture plates, 6 cm cell culture plates and cell scrapers were obtained from 
Sarstedt, Inc. (Newton, SC, USA). 
   mEmerald-Mito-7 was a gift from Michael Davidson (Addgene plasmid # 54160). 
   pCMV3-GFPSpark-NGB (Catalogue# HG15110-ANG) was obtained from Sino Biological 
Inc. (North Wales, PA, USA). 
   Anti-Ngb mouse monoclonal primary antibody (13C8) (Catalogue# ab37258) and Purified 
Recombinant Human Neuroglobin (Catalogue# ab63278) were obtained from Abcam 
(Cambridge, UK). was obtained from Abcam (Cambridge, UK). 
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   Anti-Ngb mouse monoclonal primary antibody (Catalogue# AA 1-152) was obtained from 
Merck (Boston, MA, USA). 
   Turbo DNA-free Kit (Catalogue# AM1907) was obtained from Thermo Fisher (Burlington, 
ON, Canada).    
   Monarch Plasmid Miniprep Kit (Catalogue# T1010S), Gibson Assembly Master Mix 
(Catalogue# E2611S) and Monarch DNA Gel Extraction Kit (T1020S) was obtained from New 
England Biolabs Inc.(Whitby, ON, Canada) 
   Total RNA Purification Kit (Catalogue# 37500) was obtained from Norgen Biotek (Thorold, 
ON, Canada). 
   Unless otherwise indicated, all other chemicals, reagents and solutions were purchased from 
Sigma-Aldrich (St. Louis, MO, USA), BioShop (Burlington, ON, Canada) or Fisher Scientific 
(Mississauga, ON, Canada). 
3.2.2 Methods 
3.2.2.1 Cell Culture 
MCF-7 breast cancer cells and DLD-1 colorectal cancer cells (obtained from ATCC, Manassas, 
VA, USA) were grown in Dulbecco‘s Modified Eagle Phenol Red-Free Medium (DMEM), 
supplemented with 2 mM L-glutamine, 10% charcoal-stripped FBS, 2X MEM nonessential 
amino acids, penicillin (50 I.U./mL)/streptomycin (50 µg/mL) and 4500 mg/L glucose.  
   SH-SY5Y neuroblastoma cells (obtained from ATCC, Manassas, VA, USA) were grown in 
Dulbecco‘s Modified Eagle Medium (DMEM), supplemented with 10% FBS, 2X MEM 
nonessential amino acids, penicillin (50 I.U./mL)/streptomycin (50 µg/mL), 4500 mg/L glucose, 
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4 mM L-glutamine and 1 mM sodium pyruvate for the hypoxia experiment, and were grown in 
DMEM without glucose or serum. 
   The cells were cultured in a 37℃ humidified 5% CO2 atmosphere in a Forma Series II water-
jacketed CO2 incubator. Cells were grown until 80% confluency, before being split for 
subculturing. Growth medium was removed, followed by Dulbecco PBS rinsing and addition of 
0.25% Trypsin/EDTA solution. Cells were trypsinized for approximately 3 minutes within the 
incubator. After trypsinization, media-containing FBS was added to neutralize trypsin activity. 
The mixture was then placed into conical tubes, and centrifuged for 5 minutes at 240 g; the 
supernatant was discarded and the pellet was resuspended in fresh growth medium and cells were 
replated.  
   For the hypoxia and OGD experiments, the cells were grown in a humidified hypoxia chamber, 
with all media used in these experiments pre-equilibrated in the hypoxia chamber before usage.  
   All solutions and media were pre-warmed to 37℃ in an Isotemp 110 water bath (obtained from 
Fisher Scientific, Mississauga, ON, Canada) and cell culture work was implemented within a 
Class II Type A2 biological safety cabinet (obtained from Esco Inc., Hatboro, PA, USA). 
3.2.2.2 Lysate Preparation 
   Cells were harvested using ice-cold RIPA lysis buffer (150 mM NaCl, 1% Triton-X 100, 0.5% 
sodium deoxycholate, 0.1% SDS and 50 mM Tris pH 8) and kept on ice for 30 minutes. The 
resulting lysate was centrifuged for 10 minutes at 4℃ and 10,000 g. The supernatant was then 
collected where Bradford assay was used to quantify total protein concentration; all lysates were 
stored at -80℃.  
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3.2.2.3 Western Blot 
   20 µg of total protein from lysates were added to loading buffer (containing 10%/200 mM 
DTT) in a ratio of 1:1, then boiled at 100℃ for 5 minutes. The samples were then 
electrophoresed using SDS-PAGE (sodium dodecyl sulphate-polyacrylamide gel electrophoresis) 
in a Bio-rad Mini-PROTEAN Tetra Cell apparatus for around 2 hours at 100V; 15% resolving 
gel and 5% stacking gel were used. Proteins from the gel were transferred onto PVDF 0.45 µm 
membrane within a Bio-Rad Trans-Blot semi-dry transfer apparatus for 2 hours and 30 minutes 
at 25V. The membranes were blocked with 5% milk/PBS solution at room temperature for 1 
hour.  
   For antibody incubation, membranes were incubated with anti-Ngb (1:1000) overnight on a 
rotisserie at 4℃ then washed with PBS-T 3 times (with each wash lasting 5 minutes), then 
incubated with secondary anti-mouse antibody (1:2500)  for 1 hour at room temperature. For 
loading and transfer controls, membranes were incubated with anti-Actin (1:1000) overnight on a 
rotisserie at 4℃ then washed with PBS-T 3 times (with each wash lasting 5 minutes), then 
incubated with secondary unconjugated anti-rabbit antibody (1:2500)  for 1 hour at room 
temperature. Membranes after secondary incubation were visualized via Odyssey infrared 
imaging system (LI-COR Biosciences). 
3.2.2.4 RNA Extraction and Quantitative RT-PCR 
   Cells were washed with ice-cold PBS and RNA was extracted using the Total RNA 
Purification Kit according the manufacturer‘s instructions. 1 µg RNA underwent reverse 
transcription to form cDNA via iScript cDNA Synthesis Kit in a thermocycler (25℃ for 5 
minutes, then 42℃ for 30 minutes, then 85℃ for 5 minutes and lastly 4℃ on hold). Real-Time 
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PCR was performed using CFX96 Touch Real-Time PCR Detection System (obtained from Bio-
Rad), with the Ngb forward primer sequence being: AAGGGCGGTTCTCTGGGAGCTT and 
the Ngb reverse primer sequence being: AGAGGATGTGCAGGGCCAGCTT. Each PCR was 
performed in triplicates, including the non-template control (NTC). The VEGF gene was used as 
a positive control gene for the hypoxia experiments. The housekeeping genes used were GAPD 
and PPIA for hypoxia, and GAPD only for OGD as PPIA levels changed in the OGD 
experiments. The relative level for NGB gene (shown in arbitrary units), was calculated using the 
2-ΔΔCt method.  
3.2.2.5 Ngb-EGFP Fusion Protein Construction 
   Ngb sequence from the pCMV3-GFPSpark-Ngb plasmid was amplified via PCR, using the 
Ngb forward primer sequence: ATGGAGCGCCCGGAGC and the Ngb reverse primer 
sequence: TTACTCGCCATCCCAGCCTC (see image in Appendix). The mEmerald mito-7 
plasmid underwent two different restriction cut reactions to form two different plasmid 
constructs. The NheI and BamHI restriction enzymes were used to remove the mitochondrial 
targeting sequence from the plasmid, while NheI and NotI restriction enzymes were used to 
remove both the mitochondrial targeting sequence and the EGFP (see images in Appendix).  The 
plasmid backbone from the cutting reactions of the mEmerald mito-7 plasmid and the Ngb 
sequence from the pCMV3-GFPSpark-Ngb plasmid, were extracted from their gels using the 
Monarch DNA Gel Extraction Kit. The Ngb sequence and the mEmerald plasmid backbone were 
ligated using the Gibson Assembly to form a plasmid containing either Ngb alone, EGFP alone 
or both Ngb and GFP sequences; the Ngb forward primer sequence was: 
GTTTAGTGAACCGTCAGATCCGCTAGCATGGAGCGCCCGGAGC, the Ngb reverse 
primer sequence was: 
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CACCATGGTGGCGACCGGTGGATCCCTCGCCATCCCAGCCTCGA, the Ngb alone 
reverse primer sequence was: 
GGCTGATATGATCTAGAGTCGCGGCCGCTTACTCGCCATCCCAGCCTC, the EGFP 
forward sequence was: 
GTTTAGTGAACCGTCAGATCCGCTAGCATGGTGAGCAAGGGCGAG and the EGFP 
reverse primer sequence was: 
GGCTGATATGATCTAGAGTCGCGGCCGCTTACTTGTACAGCTCGTCCATGC. The 
seams at which the ligation of the inserts occurred were sequenced at the SickKids Lab (Toronto, 
ON, Canada) to validate the success of the assembly (see sequencing results in the Appendix).   
3.2.2.6 Transient Transfection of SH-SY5Y with the newly constructed Plasmid Variants 
   SH-SY5Y cells were transiently transfected with the variants Ngb alone, EGFP alone or the 
Ngb-EGFP fusion plasmid constructs using Lipofectamine 2000 reagent, where the reagent and 
plasmid DNA were diluted in serum-free and antibiotic-free DMEM. The two solutions are then 
added to one another to form the lipid complexes and then added to the culture dishes after 5 
minutes of incubation; the ratios (µg:µL) of plasmid DNA to Lipofectamine 2000 were 1:3. 
After 24 hours, the media is replaced with normal growth media, and then the cells were used for 
live imaging and western blots.  
3.2.2.7 Confocal Microscopy 
   Live imaging of SH-SY5Y cells was undertaken using the Carl Zeiss Axio Observer.Z1 
inverted light/epifluorescence microscope equipped with ApoTome.2 optical sectioning and a 
Hamamatsu ORCA-Flash4.0 V2 digital camera. Cells were grown in phenol-red free medium 
and were viewed via a Plan-Apochromat 63x/1.40 Oil DIC M27 microscope objective. The 
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microscope stage and objective lens were warmed to 37℃ via TempModule S-controlled stage 
heater and objective heater (obtained from PeCon, Erbach, Germany); CO2 environment was 
maintained at 5% using a culture incubator. For green fluorescence detection, the fluorescence 
channel possesses excitation and emission wavelength filter sets 450-490 nm and 500-550 nm 
respectively, and set excitation and emission wavelengths of 488 nm and 509 nm respectively 
(Zeiss Item# 411003-0004-000). Z-stack series were made up of 30-40 slices, and were captured 
as single 2D images using the extended depth of focus tool using Zeiss Zen 2 (blue edition) 
software (see images in the Appendix).  
3.3 Results 
3.3.1 Ngb is not detectable in SHSY5Y cells under basal conditions or after E2 or RES 
stimulation 
   SH-SY5Y cells were treated with 10 nM E2 for 24 hours and then Ngb was probed using the 
Abcam antibody; no Ngb bands were seen (Figure 3.1).  However, purified recombinant Ngb 
was detectable under the same conditions (Figure 3.2), indicating that the Abcam antibody can 
detect Ngb. The western blot procedure was repeated using the same Abcam antibody while 
adjusting conditions.  This time semi-dry transfer was performed (see images in Appendix) with 
or without an alternative transfer buffer (Bjerrum Schaefer-Nielson Buffer: 48 mM Tris, 39 mM  
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Ladder E2 DMSO 
Negative 
Control 
17 kDa 
Ngb 
Ladder E2 DMSO 
Negative 
Control 
Tubulin 
51 kDa 
Figure 3.1 Western Blot Visualization of Ngb 
The images of the membranes show the attempted detection of 
Ngb after treatment with 10 nM E2, vehicle and negative controls 
for 24 hours. The top image shows Ngb detection and the bottom 
image shows tubulin loading control. 
Ladder Purified Ngb 
17 kDa 
Ngb 
Figure 3.2 Western Blot Visualization of Purified Ngb 
The images of the membrane show the detection of 2 µg of 
purified Ngb.  
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glycine, 20% methanol (pH 9.2); see images in Appendix).  Nonetheless, no Ngb was detected in 
SH-SY5Y cells.  
   The SH-SY5Y cells were also treated with different concentrations of E2 for 24 hours and then 
Ngb was visualized, and still, the Ngb bands remained absent on the nitrocellulose membrane 
(Figure 3.3). The cells were then treated with 10 µM of E2 (Figure 3.4a) or RES (Figure 3.4b) 
for 24 hours and then Ngb was visualized; there were no Ngb bands.  
3.3.2 Ngb mRNA expression levels were variable and similar 
   The SH-SY5Y cells were treated in the hypoxia chamber for 32 hours, with normal growth 
medium in the hypoxia experiment and with a glucose- and serum-free medium in the OGD 
experiment for 32 hours. The cells were then harvested via ice-cold PBS and centrifuged for 10 
minutes at 10000 g; the supernatant was discarded and the pellet was collected. The cells were 
then lysed using the lysis buffer provided by the kit before the RNA isolation procedure started. 
The results show that there was a significant 5 times increase in the mRNA transcript for the 
OGD experiment with respect to the control group (Figure 3.5); the Ngb mRNA transcript did 
not have a significant increase in the hypoxia experiment (Figure 3.5). The levels for VEGF 
mRNA transcripts were upregulated in the hypoxia experiment as expected (see figure in 
Appendix).  
   MCF-7 cells and DLD-1 cells were treated with 10 nM E2 for 24 hours, and then the cells were 
harvested and underwent quantitative RT-PCR. The results show that Ngb mRNA levels of 
MCF-7 (Figure 3.6a) and DLD-1 (3.6b) were quite variable, and inferences based on those 
results could not be made. The Cq values of the Non-reverse transcriptase (NRT) samples were 
similar to the actual samples, indicating genomic contamination; to eliminate genomic  
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Figure 3.3 Western Blot Visualization of Ngb with Different E2 
Concentrations and Plasmid Variant Transfections 
The image of the membrane shows the detection of Ngb after 
treatment of different E2 concentrations and negative control for 
24 hours. The last three lanes show the attempted detection of 
Ngb bands after SH-SY5Y transient transfection; the Ngb bands 
appear in the last two lanes. 
Figure 3.4 Western Blot Visualization of Ngb after Treatment with 
10 µM E2 or RES for 24 hours 
The top half images of the membranes show the detection of Ngb 
after treatment of a) E2 and b) RES. The bottom half images of a) and 
b) show the actin loading control. 
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RES Negative Control 
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contamination, the Turbo DNA-free Kit was used. MCF-7 cells were treated with 10 nM E2 for 
24 hours, then the RNA was extracted and subjected to DNAse treatment via the aforementioned 
kit; the RNA then underwent reverse transcription and PCR. The mRNA levels were still 
contaminated, indicated by the similarities between the NRTs and the actual samples (see figure 
Control 
Figure 3.5 Ngb mRNA Transcript Levels in SH-SY5Y with OGD and 
Hypoxia 
The hypoxia and OGD (b) PCR was used as a positive control for the 
success of the technique. The mRNA level is greatly upregulated in 
OGD with respect to the control (a), but is not significant in hypoxia. 
The housekeeping gene used here is GAPD.  
**: p-value <0.01 
** 
Hypoxia OGD 
Figure 3.6 Ngb mRNA Transcript Levels in MCF-7 and DLD-1 cells after 10 nM 
E2 stimulation for 24 hours 
The figure depicts the levels of Ngb mRNA transcripts after 24 hour stimulation 
with 10 nM E2. a) Shows the mRNA transcript expression level in MCF-7 and b) 
shows the mRNA transcript expression level in DLD-1. The housekeeping genes 
used here are GAPD and PPIA.  
Control DMSO 
E2 E2 
DMSO 
Control 
a b 
a 
b 
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in Appendix). The MCF-7 cells were treated 10 nM E2 for 4 hours, as literature showed that 
mRNA transcript levels peak at 4 hours (Fiocchetti et al., 2014), and then the RNA was 
extracted. The total RNA was divided into groups, where one group was subjected to DNAse 
treatment, and the second group remained without DNAse treatment. The results showed that 
genomic contamination persisted in the samples (see figure in Appendix).  
3.3.3 Ngb-EGFP fusion protein subcellular localization could not be determined 
   The SH-SY5Y cells were transfected with the three constructs (EGFP alone, Ngb alone and 
Ngb-EGFP fusion), were visualized with the confocal microscope using live imaging. As 
expected, the cells transfected with the Ngb alone plasmid construct did not show any green 
fluorescence. The cells transfected with the EGFP alone plasmid construct showed green 
fluorescence (Figure 2.3.7a) but the cells transfected with the Ngb-EGFP fusion plasmid 
construct did not show any green fluorescence (Figure 2.3.7b).  
3.3.4 Transfection confirmation was successful via western blot 
   The transiently-transfected SH-SY5Y cells were harvested after live imaging and underwent 
western blots to confirm the success of the transfection. The results showed that the bands of 
Ngb in the transfected cells were present, but the Ngb bands in the non-transfected cells were 
absent (see images in Appendix). 
3.4 Discussion 
   Protein levels of Ngb have been shown to be greatly upregulated by E2 in MCF-7 (Fiocchetti 
et al., 2014), HepG2 (Fiocchetti et al., 2014) and DLD-1 (Fiocchetti et al., 2015) across different 
concentrations and different time points. mRNA transcript levels have been shown to be greatly 
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by upregulated by E2 in the MCF-7 and HepG2 cells (Fiocchetti et al., 2014), but did not have a 
significant effect on DLD-1 cells (Fiocchetti et al., 2015). Literature also shows that E2 
stimulates the translocation of Ngb into the mitochondrial compartment in the MCF-7 (Fiocchetti 
et al., 2014), HepG2 (Fiocchetti et al., 2014) and DLD-1 cells (Fiocchetti et al., 2015). 
3.4.1 Ngb was not detectable in western blots after E2 or RES stimulation in SH-SY5Y 
   The results show that Ngb was not detectable in the western blots, whether in the negative 
control groups or in the experimental groups treated with E2 or RES; the Ngb bands detected 
were from the transfection experiments. The absence of Ngb bands could be due to low levels of 
Ngb in the SH-SY5Y cells, which is not possible as literature shows that SH-SY5Y cells express 
Ngb (Fordel et al., 2007; Fordel et al., 2007) and that E2 increase the levels of Ngb in 
neuroblastomas (De Marinis et al., 2013; Fiocchetti et al., 2013). An approach towards detection 
enhancement that could provide further insight is the horseradish peroxidase (HRP). The enzyme 
of plant origins catalyzes the conversion of certain chromogenic substrates to produce colour or 
light (depending on the substrate) which could be detected via spectrophotometry (Akkara et al., 
1991; Veitch, 2004); this catalytic activity is stimulated via an oxidizing agent, such as H2O2. 
Antibodies conjugated to HRP have been shown to have the capability of locating proteins of 
interest and producing strong and detectable signals (Chau and Lu, 1995), which is due to the 
high turnover rate of HRP (Beyzavi et al., 1987). The implementation of western blots using 
antibody-HRP conjugation could provide insight as to the basal levels of Ngb in cells. Another 
approach is to use purified Ngb in a western blot by using different dilutions in a wide dilution 
range; the detection of Ngb across different dilutions could provide further insight into Ngb‘s 
levels and detectability.  
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3.4.2 Ngb mRNA transcript levels were variable in MCF-7 and DLD-1 
   10 nM E2 stimulation for 24 hours was shown to upregulate the Ngb mRNA expression levels 
in MCF-7 cells (Fiocchetti et al., 2014), but it did not have any effect on DLD-1 cells (Fiocchetti 
et al., 2015). The results show great variability in mRNA transcript levels, which is due to the 
presence of genomic contamination as indicated by the Cq levels in the NRT samples. The 
presence of significant genomic contamination could be an indication that the homogenization of 
the samples during RNA extraction was not efficient due to the viscosity of the lysate as a result 
EGFP Brightfield Merge 
Ngb-EGFP Brightfield Merge 
Figure 3.7 Confocal Microscope Live Images of EGFP Alone Protein and the 
Ngb-EGFP Fusion Protein 
The images depict the images of SHY-SY5Y cells after the transfection of EGFP 
alone plasmid construct and the Ngb-EGFP fusion plasmid construct. a) Shows 
the fluorescence of the EGFP, with the brightfield channel being used to create 
contrast to view both transfected and non-transfected cells. These images were 
captured at 350 ms exposure time. b) Shows the fluorescence of the Ngb-EGFP 
fusion protein, with the brightfield channel being used to create contrast to view 
both transfected and non-transfected cells. These images were captured at 1500 
ms exposure time.  
b 
a 
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of DNA. Another explanation is that the Ngb mRNA transcript level is absent in the cells, which 
proves controversial as there are results that show Ngb expression in breast cancer cells 
(Fiocchetti et al., 2014; Fiocchetti et al., 2016) and there are results that state that mRNA 
transcripts are absent in breast cancer cells (Gorr et al., 2011). The variability in the mRNA 
transcript levels could be explained through the inhibition of PCR as a result of reverse 
transcription (RT); it has been shown that RT has a binding site on the Taq polymerase, which 
leads to the inhibition of the PCR and could lead to different expression levels amongst the 
different samples (Chumakov, 1994; Suslov and Steindler, 2005); heating RT before the start of 
PCR inacitivates RT (Chumakov 1994). 
   In addition to RT, but since the SYBR present in the PCR supermix solution is a dye that binds 
to double-stranded DNA in a sequence-independent manner, it could be more specific and 
sensitive if a fluorescently-labeled hybridization probe, which binds to DNA sequences in a 
specific manner, could be used (Deprez et al., 2002). Another factor that could have prevented 
results from being obtained could be the presence of DTT during the synthesis of cDNA (Deprez 
et al., 2002). Moreover, nucleic acid could adsorb to surfaces of tubes during extraction 
(Gassilloud et al., 2007; Gonzalez et al., 2007; Butot et al., 2007; Fox et al., 2007), which would 
hinder efficient RNA isolation; a detailed review of various PCR inhibitors (Schrader et al., 
2012) provide an insight to the variability of PCR results, with Sur et al., 2010 showing an 
effective method of improving PCR efficiency.   
3.4.3 Ngb-EGFP fusion protein does not fluoresce 
   Literature has shown that Ngb does re-allocate into the mitochondrial compartment via E2 
stimulation (Fiocchetti et al., 2014; Fiocchetti et al., 2015). To assess the subcellular re-
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allocation, EGFP was fused with Ngb to detect Ngb‘s translocation into the mitochondria under 
stress via confocal microscopy. However, even though the western blots confirm the success of 
the transfection, the confocal microscopy failed to detect fluorescence. The absence of 
fluorescence might be attributed to the misfolding of the Ngb-EGFP fusion protein. Another 
explanation to the absence of a detectable signal is the presence of a degron sequence on Ngb. 
   A degron is a part of the protein, which includes structural motif (Fortmann et al., 2015), 
amino acid sequence (Cho and Dreyfuss, 2010) and exposed arginine (Varshavsky, 1996) and 
lysine (Dohmen et al., 1994) residues, that regulates its degradation (Jariel-Encontre et al., 2008; 
Ravid and Hochstrasser, 2008; Erales and Coffino, 2014). Since Ngb undergoes proteasomal 
degradation, it could be speculated that the degron on Ngb is ubiquitin-dependent (Ravid and 
Hochstrasser, 2008), where it activates the polyubiquitination reaction for proteasomal 
degradation targeting (Coux et al., 1996; Lecker et al., 2006). In order to identify degrons, a 
three-step procedure must be undertaken (Ju and Xie, 2006; Schrader et al., 2009; Fortmann et 
al., 2015). 
   Firstly, the suspected degron sequence is fused to a stable protein (such as GFP) and then the 
concentrations of the altered protein and the unaltered protein over time is observed (Li et al., 
1998). If the suspected degron is actually a degron, the altered protein will degrade faster than 
the unaltered protein (Ravid and Hochstrasser, 2008; Jariel-Encontre et al., 2008; Erales et al., 
2014). To confirm the identity of the degron, a mutation of the protein containing the degron is 
formed, where the degron is removed; the mutated protein concentration should degrade slower 
than the unmutated protein (Ravid and Hochstrasser, 2008; Jariel-Encontre et al., 2008; Erales et 
al., 2014). The third step involves identifying whether the degron is ubiquitin-dependent (Ravid 
and Hochstrasser, 2008) or ubiquitin-independent (Jariel-Encontre et al., 2008; Erales et al., 
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2014). The attachment will be measured to the protein with the degron present and the protein 
with the degron absent (Loetscher et al., 1991; Shrader et al., 2009; Fortmann et al., 2015); if the 
degron is ubiquitin-dependent, then polyubiquitination will be witnessed on the protein with the 
degron present (Ravid and Hochstrasser, 2008; Fortmann et al., 2015). Since the fusion protein 
created in this study had Ngb on the terminus, it could prove insightful if the EGFP is placed on 
the N-terminus to create EGFP-Ngb, as the degron on Ngb might be on the N-degron.  
3.5 Conclusion 
The constructed plasmids expressing Ngb and EGFP-Ngb proteins were detected via 
western blots, confirming the success of transfection. However, the latter protein did not 
fluoresce compared to the control EGFP plasmid. Multiple western blot attempts failed to detect 
endogenous Ngb in SH-SY5Y cells, and the qRT-PCR results were variable in MCF-7 and DLD-
1 cells due to genomic contamination; the qRT-PCR experimentation for the hypoxia and OGD 
experiments on SH-SY5Y cells was successful, functioning as a positive control. 
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Chapter 4.0: The Effect of E2 and RES on Mitochondrial Networks under Physiological 
Stress with respect to Ngb Upregulation 
4.1 Introduction 
 Mitochondrial biogenesis is the process of increasing the number of mitochondria as a 
result of different environmental and stressful stimuli, such as an increase in ATP usage (Valero 
2014; Sanchis-Gomar et al., 2014). Mitochondrial biogenesis affects the number of mitochondria 
within cells, but other processes are required to modulate their morphology, distribution and 
function - mitochondrial fission and fusion (Bertholet et al., 2016; Mishra and Chan, 2016). The 
balance between mitochondrial fusion and fission is referred to as mitochondrial dynamics.  
Mitochondrial fission involves the fragmentation of single mitochondrial structures, 
while mitochondrial fusion involves the merger of multiple mitochondrial structures into 
elongated or networked mitochondria (Chan 2006; Mishra and Chan, 2016). Different stimuli 
have been shown to affect the mitochondrial network, by affecting the balance between fusion 
and fission (Youle and Van Der Bliek, 2012; Bertholet et al., 2016), such as the need for 
transporting more mitochondria to energy-demanding areas (Bo et al., 2010; Youle and Van Der 
Bliek, 2012). 
 Mitochondrial fission is controlled by a cytosolic dynamin (Mishra and Chan, 2016; 
Bertholet et al., 2016) – Dynamin-related Protein (DRP), which surrounds the mitochondria then 
constricts, fragmenting both the inner and outer mitochondrial membranes (Figure 4.1b; Bo et 
al., 2010). Mitochondrial fusion on the other hand is controlled by membrane-anchored dynamin 
proteins: Mitofusin (Mfn) and Optic Atrophy (Opa) (Figure 4.1a). The former is responsible for 
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the fusion of the outer membrane, while the latter is responsible for the fusion of the inner 
membrane  
 
 
 
 
 
 
 
 
(Ventura-Clapier et al., 2008; Youle and Van Der Bliek, 2012; Mishra and Chan, 2016).  Cellular 
stress affects the balance between fusion and fission, and that balance is responsible for 
maintaining mitochondrial functionality. 
 Cellular stress threatens the cells by triggering apoptosis, and a defensive mechanism to 
prevent or delay apoptosis involves damaged mitochondria fusing together to undertake genetic 
complementation; complementation of the mitochondrial genome allows defective mitochondria 
to compensate for their lack of functionality.  This procedure helps in the generation of 
functional mitochondria (Hales 2010). To provide the cell with resistance to stress, mitochondria 
tend to hyperfuse and form a highly connected network, in a process called stress-induced 
mitochondrial hyperfusion (SIMH). This form of fusion has been shown to promote ATP 
Figure 4.1 Mitochondrial fusion and fission 
The figure depicts the GTPases that control 
fusion and fission and the process that they 
undertake. a) portrays OPA1 and Mfn and the 
process of mitochondrial fusion. b) portrays 
Drp1 and the process of mitochondrial fission. 
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production (Tondera et al., 2009). The increase in mitochondrial mass, ATP production, 
activation of Bax as well as a delay in cyt c release (Tondera et al., 2009) elucidate SIMH‘s anti-
apoptotic role. Tondera et al., 2009 elucidated the role of SIMH in causing cyclin E buildup and 
regulating the progression of G1-S transition. Other studies have shown that SIMH compensates 
the reduction of ATP production in the G1-S transition (Stanton et al., 1991), protects the cells 
against apoptosis during that transition and aids in genetic complementation (Detmer and Chan, 
2007).  In addition to mitochondrial fusion, the translocation of Ngb into the mitochondria seems 
to have a putative anti-apoptotic role as well.  
 Yu et al., 2012 showed that Ngb translocates into the mitochondria during stress to exert 
a supposed anti-apoptotic role, the mechanism(s) of which has not been fully elucidated. 
However, the role of Ngb in promoting cell survival combined with its translocation into the 
mitochondria could have a connection. Khan et al., 2008 showed that Ngb helped maintain 
mitochondrial membrane potential and improved ATP production after hypoxia. Moreover, other 
studies have shown that the absence of Ngb in cells reduced the activities of Complex I and III of 
the mitochondria (Lechauve et al., 2012). Interestingly, even though Ngb translocates into the 
mitochondria, its precise localization Ngb within the mitochondrial compartment has only been 
speculated. Moreover, hyperfusion is an approach for stress resistance and fragmentation is a 
marker of apoptosis, and since Ngb translocates into the mitochondria to exert its anti-apoptotic, 
it could prove insightful to study the effects of Ngb on mitochondrial dynamics.  
Ngb over-expression can inhibit mitochondrial aggregation that occurs during hypoxia 
(Khan et al., 2008); mitochondrial aggregation is a process that precedes the release of cyt c 
(Haga et al., 2003), which would eventually lead to apoptosis. Mitochondrial aggregation occurs 
due to mitochondrial transport (Haga et al., 2003), and short-term mitochondrial movement relies 
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on the actin cytoskeleton; Antao et al., 2010 has shown that actin condensation as a result of 
hydrogen peroxide has been abrogated by Ngb. Since Ngb overexpression inhibits mitochondrial 
aggregation, which precedes the release of cyt c, and since Ngb prevents the release of cyt c, it 
could be postulated that Ngb plays a role in mitochondrial dynamics regulation.   
 In order to test the effect of Ngb on mitochondrial dynamics, as well as the effect of E2 
and RES on Ngb-mediated mitochondrial dynamic regulation, a plasmid containing Ngb 
sequence was co-transfected into SH-SY5Y cells stably expressing mEmerald mito-7. The Ngb 
EGFP fusion plasmid (mentioned in Chapter 3.0) was planned to be used in the assessment of 
mitochondrial dynamics, but since there the fluorescence was absent (see Figure 3.7 in Chapter 
3.0), the experiments could not be undertaken. The cells were treated with E2 and/or RES and 
the mitochondrial networks were visualized using Carl Zeiss microscope. Mitochondrial fusion 
and fission were assessed using an ImageJ macro called Mitochondrial Network Analysis 
(MiNA) (Valente et al., 2017). MiNA skeletonizes (Figure 4.2) mitochondrial networks, and 
quantifies the different shapes of mitochondria that indicate fusion or fission (Figure 4.3). 
4.2 Materials and Methods 
4.2.1 Materials 
   3.5 cm cell culture plates and cell scrapers were obtained from Sarstedt, Inc. (Newton, SC, 
USA). 
   Supplement-free Dulbecco‘s Modified Eagle Medium powdered media (Catalogue# 5030), L-
glutamine, sodium pyruvate (Catalogue# D7777), nonessential amino acids, 
penicillin/streptomycin solution and 0.25% trypsin/EDTA solution were obtained from Sigma-
Aldrich (St. Louis, MO, USA). 
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   Charcoal-stripped fetal bovine Serum (Catalogue# 080-750) was obtained from Wisent, Inc. 
(Saint-Jean-Baptiste, QC, Canada).  
   Nitrocellulose, 0.2 µm membrane (Catalogue# 1620112) and thick filter paper (Catalogue# 
1703969) were obtained from Bio-rad (Mississauga, ON, Canada). 
   Anti-Ngb mouse monoclonal primary antibody (Catalogue# AA 1-152) was obtained from 
Merck (Boston, MA, USA). 
   Alexa Fluor 647 donkey anti-mouse (Catalogue# A31571) was obtained from Life 
Technologies (Grand Island, NY, USA). 
   mEmerald-Mito-7 was a gift from Michael Davidson (Addgene plasmid # 54160). 
   pCMV3-GFPSpark-NGB (Catalogue# HG15110-ANG) was obtained from Sino Biological 
Inc. (North Wales, PA, USA).  
   Monarch Plasmid Miniprep Kit (Catalogue# T1010S) and Monarch DNA Gel Extraction Kit 
(T1020S) were obtained from New England Biolabs Inc.(Whitby, ON, Canada).     
   Unless otherwise indicated, all other chemicals, reagents and solutions were purchased from 
Sigma-Aldrich (St. Louis, MO, USA), BioShop (Burlington, ON, Canada) or Fisher Scientific 
(Mississauga, ON, Canada). 
4.2.2 Methods 
4.2.2.1 Cell Culture 
SH-SY5Y neuroblastoma cells (obtained from ATCC, Manassas, VA, USA) were grown 
in Dulbecco‘s Modified Eagle Medium (DMEM), supplemented with 10% charcoal-stripped 
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FBS, 2X MEM nonessential amino acids, penicillin (50 I.U./mL)/streptomycin (50 µg/mL), 4500 
mg/L glucose, 4 mM L-glutamine and 1 mM sodium pyruvate. The cells were cultured in a 37℃ 
humidified 5% CO2 atmosphere in a Forma Series II water-jacketed CO2 incubator. Cells were 
grown until 80% confluency, before being split for subculturing. Growth medium was removed, 
followed by Dulbecco PBS rinsing and addition of 0.25% Trypsin/EDTA solution. Cells were 
trypsinized for approximately 3 minutes within the incubator. After trypsinization, media-
containing FBS was added to neutralize trypsin activity. The mixture was then placed into 
conical tubes, and centrifuged for 5 minutes at 240 g; the supernatant was discarded and the 
pellet was resuspended in fresh growth medium and cells were replated. 
All solutions and media were pre-warmed to 37℃ in an Isotemp 110 water bath 
(obtained from Fisher Scientific, Mississauga, ON, Canada) and cell culture work was 
implemented within a Class II Type A2 biological safety cabinet (obtained from Esco Inc., 
Hatboro, PA, USA).  
4.2.2.2 Stable Transfection of SH-SY5Y with mEmerald mito-7 Plasmid 
The mEmerald mito-7 plasmid encoding for emerald green fluorescent protein (EGFP) 
contains an N-terminal mitochondrial targeting sequence, obtained from subunit VIII of human 
Complex IV (Planchon et al., 2011).  It was a gift from Michael Davidson (Planchon et al., 
2011). Bacteria containing the plasmid were inoculated onto agar plates containing 100 mg/mL 
kanamycin and were incubated overnight at 37℃. Single colonies from these plates were 
inoculated into LB medium containing kanamycin and incubated overnight at 37℃ in a C25KC 
shaker incubator (New Brunswick Scientific, Edison, NJ, USA). Plasmids were isolated from 
63 
 
bacterial cultures using the DNA Miniprep Kit (obtained from Norgen Biotek, Thorold, ON, 
Canada).  
SH-SY5Y cells were stable-transfected with mEmerald mito-7 plasmid using 
Lipofectamine 2000 reagent, where the reagent and plasmid DNA were diluted in serum-free and 
antibiotic-free DMEM. The two solutions are then added to one another to form the lipid 
complexes and then added to the culture dishes after 5 minutes of incubation; the ratios (µg:µL) 
of plasmid DNA to Lipofectamine 2000 were 0.5:0.5, 1:1, 1:1.5, 1.5:1.5 and 1:3. After 24 hours, 
the media is replaced with the selection DMEM with 10% FBS, 2X nonessential amino acids and 
G418 (400 µg/mL); the selection medium was changed every other day. After 10 days, the G418 
concentration was lowered to 100 µg/mL and used as a maintenance dose. The ratio used for co-
transfection experiments and live imaging involved the 1:3 ratio.  
4.2.2.3 Confocal Microscopy 
Live imaging of SH-SY5Y cells was undertaken using the Carl Zeiss Axio Observer.Z1 
inverted light/epifluorescence microscope equipped with ApoTome.2 optical sectioning and a 
Hamamatsu ORCA-Flash4.0 V2 digital camera. Cells were grown in phenol-red free medium 
and were viewed via a Plan-Apochromat 63x/1.40 Oil DIC M27 microscope objective. The 
microscope stage and objective lens were warmed to 37℃ via TempModule S-controlled stage 
heater and objective heater (obtained from PeCon, Erbach, Germany); CO2 environment was 
maintained at 5% using a culture incubator. For green fluorescence detection, the fluorescence 
channel possesses excitation and emission wavelength filter sets 450-490 nm and 500-550 nm 
respectively, and set excitation and emission wavelengths of 488 nm and 509 nm respectively 
(Zeiss Item# 411003-0004-000). Z-stack series were made up of 30-40 slices, and were captured 
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as single 2D images using the extended depth of focus tool using Zeiss Zen 2 (blue edition) 
software. 
4.2.2.4 Lysate Preparation 
Cells were harvested using ice-cold ―YY‖ lysis buffer (2X: 100 mM HEPES pH 7.5, 20% 
Glycerol, 300 mM NaCl, 2% Triton-X 100, 2 mM EDTA pH 8 and 2 mM EGTA pH 8 with 10% 
SDS added to create 1X lysis buffer and a final concentration of 0.75% SDS; protease inhibitor 
cocktail was also added to the 1X dilution) and kept on ice for 10 minutes. The resulting lysate 
was boiled at 100℃ for 5 minutes, then Bradford assay was used to quantify total protein 
concentration; all lysates were stored at -80℃.  
4.2.2.5 Western Blots 
35 µg of total protein from lysates were added to 4X loading buffer (containing 5% β-
mercaptoethanol final concentration) in a ratio of 1:3, then boiled at 100℃ for 5 minutes. The 
samples were then electrophoresed using SDS-PAGE (sodium dodecyl sulphate-polyacrylamide 
gel electrophoresis) in a Bio-rad Mini-PROTEAN Tetra Cell apparatus for around 1 hour and 35 
minutes at 125V; 13.5% resolving gel and 3% stacking gel were used. Proteins from the gel were 
transferred onto nitrocellulose 0.2 µm membrane within Owl VEP-2 Mini Tank Electroblotting 
System (obtained from Thermo Fisher, Burlington, ON, Canada) for 1 hour at 100V, with the 
apparatus being kept on ice. The membranes were blocked with 5% Bovine Serum Albumin 
(BSA)/TBS-T solution at room temperature for 1 hour.  
For antibody incubation, membranes were incubated with anti-Ngb (1:1000) overnight on 
a rotisserie at 4℃ then washed with TBS-T 3 times (with each wash lasting 5 minutes), then 
incubated with secondary anti-mouse antibody (1:5000)  for 1 hour at room temperature. For 
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loading and transfer controls, membranes were incubated with anti-Actin (1:1000) overnight on a 
rotisserie at 4℃ then washed with TBS-T 3 times (with each wash lasting 5 minutes), then 
incubated with secondary anti-rabbit antibody (1:5000)  for 1 hour at room temperature. 
Membranes after secondary incubation were visualized via ChemiDoc Imaging System (obtained 
from Bio-Rad).  
4.2.2.6 Statistical Analysis 
The statistical analyses were carried out using Statistical Package for Social Sciences 
(SPSS) using one-way ANOVAs that contained more than two groups. Normal distribution of 
the data was determined via homoscedastic checks, kurtosis, skewness and mean similarities. If 
the ANOVA tests showed a statistical significance, the post hoc tests Games-Howell (for 
heteroscedastic data) and Bonferroni (for homoscedastic data) were carried out. Statistical 
significance was determined at p-value of < 0.05. 
 
 
 
 
 
 
 
 
Figure 4.2 Skeletonizing Mitochondrial Network of Stable-
Transfected SH-SY5Y 
The image on the left shows an image from Carl Zeiss 
microscope, with the mitochondrial network coloured green. 
The image on the right depicts MiNA skeletonization for 
quantification. 
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4.3 Results 
4.3.1 Mitochondrial morphology with RES and E2 pretreatment in the presence of 
hydrogen peroxide stress for non-transfected and Ngb-transfected SH-SY5Y cells 
4.3.1.1 E2 pretreatment in Ngb-transfected SH-SY5Y cells decreased mitochondrial     
individual number but did not affect network number or mean network size 
   Both Ngb-transfected and non-transfected SH-SY5Y cells were treated with 10 µM E2 for 24 
hours, then were treated with 300 µM H2O2 for 2 hours. The cells were then imaged and 
analyzed as mentioned above. For the individuals parameter, there was a significant increase in 
mitochondrial individuals of the H2O2 treatment in Ngb-transfected SH-SY5Y cells in 
Figure 4.3 Quantification of Mitochondria based on Different 
Shapes 
The image on the left depicts mitochondrial networks, with 
different mitochondrial shapes being highlighted in yellow. 
The diagrams on the right portray the different shapes that 
assess fusion or fission, with networks indicating fusion and 
individuals indicating fission. The image was obtained from 
Valente et al., 2017. 
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comparison with the non-transfected cells of the control group (p-value < 0.05) (Figure 4.4a) and 
the non-transfected cells treated with H2O2 (p-value < 0.01) (Figure 4.4b). In addition, the Ngb-
transfected cells that have been pretreated with E2 then treated with H2O2 had a significant 
decrease in mitochondrial individual number with respect to the Ngb-transfected cells treated 
with H2O2 (p-value < 0.05) (Figure 4.4c).  
   For the network parameter, there were no significant differences in mitochondrial network 
numbers between the H2O2 treatment in Ngb-transfected SH-SY5Y cells, the non-transfected 
cells of the control group (Figure 4.5a) and the non-transfected cells treated with H2O2 (Figure 
4.5b). Moreover, the Ngb-transfected cells that have been pretreated with E2 then treated with 
H2O2 did not show any significant differences in network number with the Ngb-transfected cells 
treated with H2O2 (Figure 4.5c).  
   As for the mean network size (Figure 4.6), there was no significant effect on the number of 
branches per network across all treatment groups with respect to both the Ngb-transfected and 
non-transfected cells. 
4.3.1.2 RES pretreatment in Ngb-transfected SH-SY5Y cells decreased mitochondrial     
individual number but did not affect network number or mean network size 
   The Ngb-transfected and non-transfected SH-SY5Y cells were treated with 10 µM RES for 24 
hours, then were treated with 300 µM H2O2 for 2 hours in the similar manner as the E2 
pretreatment groups, before undergoing imaging and analysis. With regards to the individuals 
parameter, there was no significant difference between the H2O2 treatment in Ngb-transfected 
SH-SY5Y cells and the non-transfected cells of the control group (Figure 4.7a), but showed a 
significant increase with respect to and the non-transfected cells treated with H2O2 (p-value <  
b a 
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Figure 4.4 Quantification of Mitochondrial Individuals after Estradiol Pretreatment 
under Hydrogen Peroxide Stress 
The figures portray the differences in the number of mitochondrial individuals. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under H2O2 stress. (b) shows the comparison between the 
non-transfected SH-SY5Y cells under H2O2 stress with the Ngb-transfected SH-SY5Y cells 
under H2O2 stress. (c) shows the comparison between the Ngb-transfected SH-SY5Y cells 
under H2O2 stress and Ngb-transfected SH-SY5Y cells under H2O2 stress after estradiol 
pretreatment. Data is represented as mean ± SEM. 
*: indicates p-value <0.05 
**: indicates p-value <0.01 
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Figure 4.5 Quantification of Mitochondrial Networks after Estradiol Pretreatment under 
Hydrogen Peroxide Stress 
The figures portray the differences in the number of mitochondrial networks. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under H2O2 stress. (b) shows the comparison between the 
non-transfected SH-SY5Y cells under H2O2 stress with the Ngb-transfected SH-SY5Y cells 
under H2O2 stress. (c) shows the comparison between the Ngb-transfected SH-SY5Y cells 
under H2O2 stress and Ngb-transfected SH-SY5Y cells under H2O2 stress after estradiol 
pretreatment. Data is represented as mean ± SEM. 
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0.01) (Figure 4.7b). Furthermore, the Ngb-transfected cells that have been pretreated with RES 
then treated with H2O2 had a significant decrease in individuals in comparison to the non-
transfected cells treated with H2O2 (p-value < 0.05) (Figure 4.7c).  
   With regards to the number of networks, there were no significant differences between the 
H2O2 treatment in Ngb-transfected SH-SY5Y cells, the non-transfected cells of the control group 
(Figure 4.8a) and the non-transfected cells treated with H2O2 (Figure 4.8b). In addition, the Ngb-
transfected cells that have been pretreated with RES then treated with H2O2 did not show any  
Figure 4.6 Quantification of Mitochondrial Mean Network Sizes after Estradiol 
Pretreatment under Hydrogen Peroxide Stress 
The figure portrays the differences in the number of mitochondrial branches per network. 
The left side of the figure depicts the non-transfected SH-SY5Y cells under various 
conditions of treatments, while the right side of the figure depicts the Ngb-transfected 
SH-SY5Y cells under the same conditions of treatment. Data has been normalized to the 
controls of each form of transfection and is represented as mean ± SEM. 
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Figure 4.7 Quantification of Mitochondrial Individuals after Resveratrol Pretreatment 
under Hydrogen Peroxide Stress 
The figures portray the differences in the number of mitochondrial individuals. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under H2O2 stress. (b) shows the comparison between the 
non-transfected SH-SY5Y cells under H2O2 stress with the Ngb-transfected SH-SY5Y cells 
under H2O2 stress. (c) shows the comparison between the non-transfected SH-SY5Y cells 
under H2O2 stress and Ngb-transfected SH-SY5Y cells under H2O2 stress after resveratrol 
pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value <0.01 
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Figure 4.8 Quantification of Mitochondrial Networks after Resveratrol Pretreatment 
under Hydrogen Peroxide Stress 
The figures portray the differences in the number of mitochondrial networks. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under H2O2 stress. (b) shows the comparison between the 
non-transfected SH-SY5Y cells under H2O2 stress with the Ngb-transfected SH-SY5Y cells 
under H2O2 stress. (c) shows the comparison between the non-transfected SH-SY5Y cells 
under H2O2 stress and Ngb-transfected SH-SY5Y cells under H2O2 stress after resveratrol 
pretreatment. Data is represented as mean ± SEM. 
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significant differences in mitochondrial network number in comparison with the non-transfected 
cells treated with H2O2 (Figure 4.8c).  
   For the mean network size (Figure 4.9), there were no significant differences in branch number 
per network across all treatment groups with regards to both the Ngb-transfected and non-
transfected cells. 
4.3.2 Mitochondrial morphology with RES and E2 pretreatment in hypoxic conditions for 
non-transfected and Ngb-transfected SH-SY5Y cells  
4.3.2.1 E2 pretreatment in Ngb-transfected SH-SY5Y cells increased mitochondrial     
individual number and mitochondrial network number but did not affect mean 
network size 
   The Ngb-transfected cells and the non-transfected cells were pretreated with 10 µM E2 for 24 
hours then incubated in hypoxic conditions for 24 hours, before undergoing reoxygenation for 3 
hours. After that, the cells were visualized using the Carl Zeiss microscope then the 
mitochondrial networks were quantified using the MiNA macro. With regards to the 
mitochondrial individual number, there was no significant difference in the individuals of 
hypoxia/reoxygenation-treated Ngb-transfected cells in comparison with the non-transfected 
cells of the control group (Figure 4.10a), but there was a significant increase in the individual 
number of the former with respect to the hypoxia/reoxygenation-treated non-transfected cells (p-
value < 0.01) (Figure 4.10b). The E2-pretreated hypoxia/reoxygenation-treated Ngb-transfected 
cells showed a significant increase in individuals in comparison with hypoxia/reoxygenation-
treated Ngb-transfected cells (Figure 4.10c).  
    
b a 
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Figure 4.9 Quantification of Mitochondrial Mean Network Sizes after Resveratrol 
Pretreatment under Hydrogen Peroxide Stress 
The figure portrays the differences in the number of mitochondrial branches per network. 
The left side of the figure depicts the non-transfected SH-SY5Y cells under various 
conditions of treatments, while the right side of the figure depicts the Ngb-transfected 
SH-SY5Y cells under the same conditions of treatment. Data has been normalized to the 
controls of each form of transfection and is represented as mean ± SEM. 
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Figure 4.10 Quantification of Mitochondrial Individuals after Estradiol Pretreatment 
under Hypoxic Stress 
The figures portray the differences in the number of mitochondrial individuals. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under hypoxic stress. (b) shows the comparison between 
the non-transfected SH-SY5Y cells under hypoxic stress with the Ngb-transfected SH-SY5Y 
cells under hypoxic stress. (c) shows the comparison between the Ngb-transfected SH-
SY5Y cells under hypoxic stress and Ngb-transfected SH-SY5Y cells under hypoxic stress 
after estradiol pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value <0.01 
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   For the number of mitochondrial networks, there was no significant difference in networks 
between hypoxia/reoxygenation-treated Ngb-transfected cells and the non-transfected cells of the 
control group (Figure 4.11a), but a significant increase in networks was shown in the former with 
respect to hypoxia/reoxygenation-treated non-transfected cells (p-value < 0.01) (Figure 4.11b). 
Lastly, the E2-pretreated hypoxia/reoxygenation-treated Ngb-transfected cells showed a 
significant increase in network number in comparison with the hypoxia/reoxygenation-treated 
non-transfected cells (p-value < 0.01) (Figure 4.11c).  
   As for the mean network size (Figure 4.12), there was no significant effect on the number of 
branches per network under hypoxic conditions with respect Ngb-transfection and non-
transfection. 
4.3.2.2 RES pretreatment in Ngb-transfected SH-SY5Y cells decreased mitochondrial           
individual number, increased mitochondrial network number but did not affect mean 
network size 
    Both the Ngb-transfected cells and the non-transfected cells were pretreated with 10 µM RES 
for 24 hours before undergoing a 24-hour incubation period in hypoxic conditions for 24 hours; 
the cells were then reoxygenated for 3 hours before imaging and analysis. For the mitochondrial 
individual parameter, there was a significant increase in the individuals of 
hypoxia/reoxygenation-treated Ngb-transfected cells in comparison with the non-transfected 
cells of the control group (p-value < 0.01) (Figure 4.13a), but there was a significant decrease in 
the individual number of the former with respect to the hypoxia/reoxygenation-treated non-
transfected cells (p-value < 0.01) (Figure 4.13b). The RES-pretreated hypoxia/reoxygenation- 
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Figure 4.11 Quantification of Mitochondrial Networks after Estradiol Pretreatment 
under Hypoxic Stress 
The figures portray the differences in the number of mitochondrial networks. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under hypoxic stress. (b) shows the comparison between 
the non-transfected SH-SY5Y cells under hypoxic stress with the Ngb-transfected SH-SY5Y 
cells under hypoxic stress. (c) shows the comparison between the non-transfected SH-
SY5Y cells under hypoxic stress and Ngb-transfected SH-SY5Y cells under hypoxic stress 
after estradiol pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value < 0.01 
78 
 
 
 
 
treated Ngb-transfected cells showed a significant decrease in individuals in comparison with 
hypoxia/reoxygenation-treated Ngb-transfected cells (Figure 4.13c).  
   As for the mitochondrial network parameter, there was no significant difference shown 
between hypoxia/reoxygenation-treated Ngb-transfected cells and the non-transfected cells of the 
control group (Figure 4.14a), but a significant increase in networks was shown in the former with 
respect to hypoxia/reoxygenation-treated non-transfected cells (p-value < 0.01) (Figure 4.14b). 
For the RES-pretreated hypoxia/reoxygenation-treated Ngb-transfected cells, a significant 
increase was shown in comparison with the hypoxia/reoxygenation-treated non-transfected cells 
(p-value < 0.01) (Figure 4.14c).  
Figure 4.12 Quantification of Mitochondrial Mean Network Sizes after Estradiol 
Pretreatment under Hypoxic Stress 
The figure portrays the differences in the number of mitochondrial branches per network. 
The left side of the figure depicts the non-transfected SH-SY5Y cells under various 
conditions of treatments, while the right side of the figure depicts the Ngb-transfected 
SH-SY5Y cells under the same conditions of treatment. Data has been normalized to the 
controls of each form of transfection and is represented as mean ± SEM. 
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Figure 4.13 Quantification of Mitochondrial Individuals after Resveratrol Pretreatment 
under Hypoxic Stress 
The figures portray the differences in the number of mitochondrial individuals. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under hypoxic stress. (b) shows the comparison between 
the non-transfected SH-SY5Y cells under hypoxic stress with the Ngb-transfected SH-SY5Y 
cells under hypoxic stress. (c) shows the comparison between the Ngb-transfected SH-
SY5Y cells under hypoxic stress and Ngb-transfected SH-SY5Y cells under hypoxic stress 
after estradiol pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value <0.01 
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Figure 4.14 Quantification of Mitochondrial Networks after Resveratrol Pretreatment 
under Hypoxic Stress 
The figures portray the differences in the number of mitochondrial networks. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under hypoxic stress. (b) shows the comparison between 
the non-transfected SH-SY5Y cells under hypoxic stress with the Ngb-transfected SH-SY5Y 
cells under hypoxic stress. (c) shows the comparison between the non-transfected SH-
SY5Y cells under hypoxic stress and Ngb-transfected SH-SY5Y cells under hypoxic stress 
after estradiol pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value < 0.01 
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     Lastly, there was no significant difference on the mean network size (Figure 4.16) under 
hypoxic conditions regardless of the transfection and treatment Ngb-transfection and non-
transfection. 
 
 
 
 
 
 
 
 
 
 
4.4 Discussion 
Ngb is a haem protein that has been shown to protect cells against oxidative stress. Ngb 
silencing promotes apoptosis caused by various forms of oxidative stress (Li et al., 2007; 
Watanabe et al., 2012; ). In contrast, Ngb overexpression confers neuronal cells with protective 
capabilities against oxidative stress or hypoxia/ischemia stress (Sun et al., 2001; Li et al., 2008; 
Li et al., 2008; Watanabe and Wakasugi, 2008). Ngb upregulation has been shown to occur 
Figure 4.15 Quantification of Mitochondrial Mean Network Sizes after Resveratrol 
Pretreatment under Hypoxic Stress 
The figure portrays the differences in the number of mitochondrial branches per network. 
The left side of the figure depicts the non-transfected SH-SY5Y cells under various 
conditions of treatments, while the right side of the figure depicts the Ngb-transfected 
SH-SY5Y cells under the same conditions of treatment. Data has been normalized to the 
controls of each form of transfection and is represented as mean ± SEM. 
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immediately following exposure to an oxidative stress (Watanabe and Wakasugi, 2008; Emara et 
al., 2010; Oleksiewicz et al., 2011), which could explain how cancer cells survive oxidative 
stress or hypoxic insults that occur in neoplastic tissue (Emara et al., 2010; Oleksiewicz et al., 
2011). Since fission is a marker of cellular stress and fusion is a marker of stress resistance, Ngb 
translocates into mitochondria during cellular stress, combined with Ngb‘s translocation into 
mitochondria under stress, it could be hypothesized that Ngb affects mitochondrial dynamics. 
4.4.1 Ngb alone does not prevent mitochondrial fragmentation   
For the hydrogen peroxide stress experiment, an increase in individual number was 
shown in the Ngb-transfected SH-SY5Y cells. The individual number parameter indicates 
mitochondrial fragmentation and it could be assumed that the results indicate that the 
aforementioned group showed a phenotype with an increase in mitochondrial fragmentation. 
Combined with the non-significant differences in network number and mean network size, it 
could be postulated that the overexpression of Ngb without any form of pretreatment did not 
prevent the formation of punctae and rod-shaped mitochondria, a sign of fragmentation. 
However, E2 or RES pretreatment in the Ngb-transfected cells showed a significant decrease in 
individual formation, hinting at the prevention of fragmentation, which agrees with the evidence 
that shows RES‘s ability to ameliorate mitochondrial fission under stress (Wang et al., 2014; Li 
et al., 2016); the protective effects of RES on mitochondria have been reviewed by Ungvari et 
al., 2011. 
The overexpression of Ngb alone did not seem to abrogate mitochondrial fragmentation 
as a result of H2O2 insult, which could argue Ngb‘s role in mitochondrial dynamics as one of its 
anti-apoptotic effects; Ngb‘s role could be limited to other elucidated mechanisms, such as ROS 
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scavenging (Herold et al., 2004; Fordel et al., 2006; Fordel et al., 2007; Li et al., 2008) and GDI 
activity (Watanabe et al., 2012). It could also be due to the misfolding of the Ngb protein from 
the plasmid transfection, as mentioned in Chapter 2.    
Hypoxia has been shown to increase production of ROS (Fridovich, 1978; Yoshikawa et 
al., 1982; Block et al., 1989; Chang et al., 1989; Kehrer et al., 1990), although other evidence 
exists that shows a reduction in ROS production as a result of hypoxic insult (de Groot and 
Littauer, 1989). There is also evidence that reoxygenation induces an increase in ROS production 
(Arroyo et al., 1990). As mentioned earlier, an increase in ROS production would lead to 
mitochondrial fragmentation, and eventually apoptosis.  
For the hypoxic stress experiments, the overexpression of Ngb without any form of 
pretreatment showed an increase in the number of punctae and rod-shaped mitochondria. In 
addition to the increase of individual number, the increase in network number and the non-
significant difference in mean network size indicate that the larger networks are being 
fragmented into smaller networks as well as punctae and rod-shaped mitochondria; this evidence 
shows that Ngb overexpression, by itself, could not ameliorate mitochondrial fragmentation. 
However, RES pretreatment in Ngb-transfected cells showed a decrease in individual number 
and an increase in network number, which would indicate that fragmentation, was limited to the 
formation in smaller networks from larger networks, instead of punctae and rod-shaped 
mitochondria; this could be due to RES‘s promotion of the expression of mitochondrial fission 
protein (Peng et al., 2015).  
Moreover, E2 pretreatment in Ngb-transfected cells showed a significant increase in 
individual and network number. Combined with the lack of significant difference in mean 
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network size, the larger networks seem to undergo fragmentation into smaller networks as well 
as punctae and rod-shaped mitochondria. The failure to ameliorate fragmentation by the ERβ 
agonists could have been associated with the low concentrations used (10 µM) for a short 
pretreatment period (24 hours); an increase in the concentration of RES combined with a longer 
pretreatment period could help with the reduction of fragmentation, as a similar approach was 
undertook by Wang et al., 2014.  
4.4.2 Ngb does not induce mitochondrial fusion 
The number of network parameters is used to quantitavely asses the degree of 
mitochondrial fusion, as fission fragments mitochondrial networks during apoptosis to aid in the 
release of pro-apoptotic proteins (Parone and Martinou, 2006; Suen et al., 2008); there is 
evidence that elucidates the inhibition of fusion during apoptosis (Karbowski et al, 2004), 
indicating that fusion has an antiapoptotic activity.  
An increase in the number of branches per network (mean network size) indicates that 
networks are elongating and creating more branches, a sign of fusion. Increased fusion with 
mitochondria leads to a highly connected network (hyperfusion), and provides resistance towards 
apoptosis. Tondera et al., 2009 has shown the different effects of hyperfusion within the cell, 
such as delaying the release of cyt c and increasing ATP production; it could be postulated that 
Ngb exacts its anti-apoptotic also by preventing cyt c release through the induction of 
hyperfusion. Across all forms of groups, regardless of presence or absence of overexpressed 
Ngb, there were no significant differences in the number of branches per network. The 
overexpression of Ngb alone did not show any significant increases in the elongation of networks 
through the formation of more branches within the mitochondrion, indicating that Ngb may not 
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have a role in mitochondrial fusion. The pretreatment with E2 and RES in the Ngb-transfected 
cells also did not increase the formation of branches in a network. These results could be 
explained by the lack of any role Ngb has on mitochondrial dynamics as a protective mechanism 
for SH-SY5Y cells. With regards to the pretreatment, it could be that the low concentrations for a 
short pretreatment period, as mentioned above, was not enough to abrogate the deleterious 
effects of hypoxia and reoxygenation. 
4.5 Conclusion 
The constructed plasmid expressing the Ngb protein was present within cells, indicated 
by the Ngb bands from western blots that validate the success of transfection. However, Ngb  
alone did not prevent mitochondrial fragmentation nor did it induce mitochondrial fusion and 
network elongation, while the combined effects of E2 and RES pretreatments with Ngb seemed 
to abrogate mitochondrial fragmentation in oxidative stress. 
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5.0 Discussion 
5.1 No evidence that neuroglobin inhibits cytochrome c peroxidase activity 
As previously mentioned, Ngb interacts with cyt c by reducing it and preventing 
apoptosome formation. This interaction, which was shown to be very rapid (Fago et al., 2008), is 
thought to be electrostatic, as the pI of Ngb is 4.6 (acidic) and that of cyt c is 10.2 (basic) 
(Brittain et al., 2010). Another form of interaction is a direct docking interaction (Figure 5.1), 
which showed that the cyt c residues (Lys25 and Lys72) binding with Ngb are also pivotal for 
cyt c – Apaf-1 binding (Kluck et al., 2000; Yu et al., 2001; Abdullaev et al., 2002; Chertkova et 
al., 2008) and apoptosome formation. Due to these interactions between cyt c and Ngb, 
combined with Ngb‘s translocation into the mitochondria to interact with cyt c and inhibit 
apoptosis as mentioned earlier, it could be hypothesized that Ngb could prevent cyt c release by 
inhibiting its peroxidase activity; cyt c peroxidase activity leads to cyt c‘s detachment from 
cardiolipin and its eventual release.  
The significant increase in the fluorescence measurement of the peroxidase activity with 
cyt c and cardiolipin compared to cyt c alone was expected, since the cyt c peroxidase activity is 
prominently activated as a result of cyt c and cardiolipin interaction, which agrees with literature 
( see Figure 2.2 in Chapter 2; Petrosillo et al., 2001; Kagan et al., 2005); this increase in 
fluorescence is a result of the exposure of cyt c‘s haem group towards H2O2 due to the 
interaction with cardiolipin, which inexorably activates cyt c‘s peroxidase activity. However, the 
fluorescence measurement with the addition of Ngb (cyt c, cardiolipin and Ngb) was not 
significantly different from the measurements of cyt c and cardiolipin, which shows that Ngb did 
not inhibit cyt c‘s peroxidase activity.   
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The non-significant difference between the measurement of the fluorescence after the 
addition of Ngb and the measurement with cardiolipin and cyt c only indicates that Ngb does not 
inhibit the activation of cyt c‘s peroxidase activity in a 1:1 ratio. The concentrations of cyt c 
differ amongst organs and species (Potter and DuBois, 1942). Forman and Azzi, 1997 showed 
that cyt c‘s concentration in cardiomyocytes within the intermembrane space ranges from 0.5 to 
5 mM, with its cytosolic concentration being approximately 0.46 mM (van Beek-Harmsen and 
van der Laarse, 2005; another study showed that 0.04 ng/mL cyt c is released from intact isolated 
rat heart mitochondria (Appaix et al., 2000). In the HL-60 promyeolocytic leukemia cells, it was 
shown that intracellular cyt c concentration was around 7 µM (Ripple et al., 2010). Ott et al., 
2002, showed that around 0.1 µM of cyt c is free in the intermembrane space and can be released 
Figure 5.1 Docking Structure of Ngb-Cytochrome c 
Complex 
The figure depicts a physical interaction between cyt c and 
Ngb, where the Lys25 and Lys72 on cyt c bind with Gluc67 
and Glu60 on Ngb. This structure was calculated using 
BIGGER (Palma et al., 2000) and rendered using YASARA. 
This image was obtained from Raychaudhuri et al., 2010.  
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easily once a mild apoptotic signal is triggered, with more cyt c being released if a strong 
apoptotic signal is triggered. Ngb concentrations in retinal rods and endocrine tissues reach 
levels as high as 100 µM (Hankeln et al., 2005). Although the concentrations of Ngb within the 
mitochondria, as well as ratios of Ngb to cyt c concentrations, have not been elucidated, 
Raychaudhuri et al., 2010 showed decreased apoptosome formation and inhibition of caspase 9 
at different Ngb concentrations (0, 0.01 µM and 0.1 µM) and constant cyt c levels (0.1 µM); it 
was shown that the apoptosome formation inhibition was Ngb dose-dependent. Increasing the 
levels of cyt c from 0.1 µM to 0.2 µM showed a 15-fold increase in caspase 3 activation (non-
linear manner), requiring higher levels of Ngb to inhibit apoptosis; Ngb levels at 0.5 µM with 
respect to cyt c levels at 0.2 µM inhibited apoptosis (Raychaudhuri et al., 2010). This shows that 
effective ratio between Ngb and cyt c with regards to inhibition to apoptosis is 3:1. Although 
there is no evidence with regards to Ngb inhibiting the peroxidase activity of cyt c, it could prove 
insightful if a 3:1 Ngb to cyt c ratio is investigated for that assay. However, the results from such 
an experiment might not be extrapolated as the probability of the 3:1 ratio occurring 
physiologically within the mitochondria is too low.      
The lack of inhibition could be attributed to nature of interaction between Ngb and cyt c, 
where Ngb inactivates the apoptotic effect of cyt c by reducing it to the ferrous form (Suto et al., 
2005; Borutaite and Brown, 2007; Brown and Borutaite, 2008). The lack of inhibition could also 
be due to the fact the anti-apoptotic effects occur when the ratio of Ngb to cyt c is 3:1 
(Raychaudhuri et al., 2010). Other than the nature of interaction, the differences in localization 
between cyt c and Ngb could justify these results. 
              Ngb translocates into the mitochondria, however its exact location has not been clearly 
indicated. Ngb has been shown to localize in the mitochondrial matrix, as a result of Ngb 
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presence detected in mitoplasts; mitoplasts are mitochondria that lack outer membranes and 
intermembrane spaces (Lechauve et al., 2012). However, interaction between Ngb and cyt c has 
been elucidated in the literature (De Marinis et al., 2013); although the nature of the interaction 
between Ngb and cyt c has not been elucidated, immunopreciptation blots of the mitochondrial 
fraction for Ngb and cyt c indicates that Ngb interacts with cyt c in the mitochondrial fraction. 
Another explanation for the lack of inhibition of the cyt c peroxidase activity with Ngb is that 
Ngb does not interfere with the peroxidase activity, but mainly functions as a ROS scavenger 
(Herold et al., 2004; Fordel et al., 2007), and thus, Ngb does not prevent the activity of cyt c 
peroxidase. Furthermore, Ngb binding with cyt c could require the released active ferric form of 
cyt c (Pan et al., 1999; Suto et al., 2005), hinting that the interaction between Ngb and cyt c 
occurs only in the cytoplasm, which still contradicts the literature that a Ngb-cyt c interaction in 
the mitochondria occurs (De Marinis, 2013).  
5.2 Endogenous Ngb is undetectable in SH-SY5Y cell lysates 
The western blots performed to visualize endogenous Ngb and the effects of E2 and RES 
on its expression failed to detect Ngb under any condition tested.  On the other hand, Ngb bands 
were readily detectable in lanes with pure recombinant Ngb or with cells in which Ngb had been 
overexpressed, indicating that the technique undertaken was efficient. The absence of 
endogenous Ngb bands could not be interpreted as lack of Ngb expression in this cell line, as 
SH-SY5Y cells have been shown previously to express Ngb protein (Fordel et al., 2007a; Fordel 
et al., 2007b), and that E2 greatly increases the levels of Ngb in the SK-N-BE neuroblastoma cell 
lines (De Marinis et al., 2013; Fiocchetti et al., 2013). It could be speculated that the reasons 
behind the lack of Ngb bands are that Ngb protein levels are quite low combined with a low 
sensitivity detection method, evident by the lack of bands on a 0.2 µm nitrocellulose membrane. 
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To provide insight into the levels of Ngb, a western blot with a wide dilution range of purified 
Ngb protein should be undertaken, to determine the lowest dilution at which the band could be 
visualized. Another method to aid in Ngb detection could be the use of chemiluminescence, 
which uses substrates for HRP, as the infra-red detection method for the unconjugated antibodies 
and the fluorescence detection for the Alexa-Fluor conjugated antibody were ineffective. The 
HRP detection has been shown to provide strong and detectable signals (Chau and Lu, 1995). In 
multiple attempts to replicate various studies (Fiocchetti et al 2014; Fiocchetti et al., 2015; 
Fiocchetti et al., 2016), the visualization detection method of Ngb bands on the membranes was 
different from those studies; the aforementioned studies used the super power ECL (enhanced 
chemiluminescence) HRP substrate, which was successful in visualizing Ngb bands. Since the 
western blots failed to show any Ngb bands, it could be safe to assume that the detection via 
chemiluminescence is essential to Ngb visualization. 
 5.3 Ngb mRNA transcript levels could not be accurately quantified in MCF-7 or DLD-1 
cells but showed overexpression in SH-SY5Y cells that underwent OGD 
Quantitative RT-PCR was performed on SH-SY5Y cells that were treated in hypoxic and 
OGD conditions to be used as a positive control for the success of the technique (chapter 3.0). 
Briefly, SH-SY5Y cells were placed in a humidified hypoxic chamber for both the hypoxia and 
OGD experiments, with the media for OGD lacking in FBS and glucose. The cells were 
incubated for 32 hours, and then were harvested via ice-cold PBS and the pellet collected. After 
the RNA isolation and cDNA synthesis, the cDNA underwent PCR to quantify Ngb mRNA 
transcript levels. The levels of Ngb mRNA were significantly higher in comparison with the 
hypoxia and control groups, which is concordant with the results from Fordel et al., 2007a. The 
10 nM E2 stimulation for 24 hours however showed great variability in the results, preventing 
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any solid conclusions. Fiocchetti et al., 2014 showed that 10 nM E2 stimulation for 24 hours 
increased the levels of Ngb mRNA transcripts in MCF-7 cells in contrast with the DLD-1 cells, 
where there was no significant effect on the Ngb mRNA transcript levels (Fiocchetti et al., 
2015). The presence of genomic contamination caused great variability in the mRNA expression 
levels, which was confirmed by the similarities of NRT Cq levels. Even though a study shows 
the absence of Ngb mRNA transcripts within MCF-7 cells (Gorr et al., 2011), other studies 
confirm the presence of the Ngb mRNA transcript level in the cells (Fiocchetti et al., 2014; 
Fiocchetti et al., 2016).In this study, both the MCF-7 and DLD-1 cells were used for the 
quantification of Ngb mRNA transcript levels, and the levels were quite variable compared to the 
results used in Fiocchetti et al., 2014, Fiocchetti et al., 2015 and Fiocchetti et al., 2016. The RNA 
isolation used in the aforementioned studies involved the use of the TRIzol reagent, while the 
RNA isolation used in this study was the Total RNA Isolation Kit from Norgen, using the ―on-
column‖ method. The on-column method was used to extract pure RNA with minimal genomic 
contamination. However, due to the nature and morphology of the MCF-7 and DLD-1 cells, 
which tend to adhere together during lysis, a TRIzol reagent would prove useful for such a great 
amount of contamination presence. This is because the TRIzol reagent separates the homogenate 
into different layers, with the RNA being separated into a layer of its own, allowing for a more 
effective RNA isolation; the RNA is then precipitated via isopropanol.   
5.4 Ngb-EGFP fusion protein could not be visualized despite being detectable by western 
blot 
Studies have shown that Ngb translocates into mitochondria when cells are stressed, and 
that translocation is E2-dependent (De Marinis et al., 2013; Fiocchetti et al., 2014; Fiocchetti et 
al., 2015; Fiocchetti et al., 2016). To visualize this translocation, I constructed EGFP, Ngb and 
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Ngb-EGFP fusion constructs for the fusion protein expression. SH-SY5Y cells were transfected 
with either of Ngb or Ngb-EGFP fusion plasmids expressing either Ngb alone or an Ngb-EGFP 
fusion protein respectively. Unfortunately, I was unable to detect the fusion protein using 
confocal microscopy, though positive controls including EGFP alone could be detected. The 
western blots performed to confirm the success of transfection showed Ngb bands, indicating 
expression from plasmids; however, western blots do not indicate functionality. The absence of 
fluorescence could be due to misfolding of the fusion protein, or the presence of a degron in its 
sequence. 
Degrons are sequences of proteins that regulate protein degradation (Jariel-Encontre et 
al., 2008; Ravid and Hochstrasser, 2008; Erales and Coffino, 2014). As mentioned before, Ngb 
has been shown to undergoe proteasomal degradation, indicating that Ngb‘s degron is ubiquitin-
dependent (Ravid and Hochstrasser, 2008). An N-degron sequence on Ngb has been identified, 
and could explain the lack of fluorescence from the Ngb-EGFP fusion protein, and would lead to 
the degradation of Ngb, which would lead to a higher turnover rate, preventing the correct 
formation and maturation of Ngb-EGFP. A solution to such a predicament is fusing the EGFP 
sequence at the N-terminus, overcoming the high turnover rate of Ngb. The EGFP-Ngb fusion 
plasmid construct could then be transfected into the SH-SY5Y cells and visualized using the 
confocal microscope to determine correct folding and the presence of fluorescence; once the 
fluorescence presence is confirmed, Ngb translocation under different conditions could be 
assessed and mitochondrial network characteristics could be quantified more directly.  
5.5 Ngb overexpression did not affect mitochondrial network characteristics 
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Ngb‘s role in inducing mitochondrial fusion and hyperfusion has not been elucidated. 
Due to the translocation of Ngb into mitochondria, where it exerts its protective action, it could 
be speculated that Ngb might induce mitochondrial fusion (Wang, 2013) to prevent apoptosis. 
MiNA was used to quantify mitochondrial networking characteristics, which involves the 
skeletonizing mitochondria after taking images of mitochondria-containing EGFP in SH-SY5Y.  
The skeletonized mitochondria are then categorized into their respective parameters and 
quantified; interestingly, Ngb lacked a significant effect on mitochondrial network formation.  
The parameters used to characterize mitochondrial networking included, but not limited 
to, individual number, network number and mean network size. The individual number 
parameter is a marker of mitochondrial fragmentation and it could be speculated that an increase 
in individual number is interpreted as an increase in mitochondrial fragmentation as fission 
fragments mitochondrial networks during apoptosis to aid in the release of pro-apoptotic proteins 
(Parone and Martinou, 2006; Suen et al., 2008). The network number parameter however, is a 
marker of mitochondrial fusion, and in contrast to the pro-apoptotic effect of fission, fusion 
promotes anti-apoptotic effects as there is evidence that shows inhibition of fusion during 
apoptosis (Karbowski et al, 2004). The mean network size (number of branches per network) 
parameter is a marker of fusion, which involves the formation of a highly connected network that 
confers different effects (Tondera et al., 2009) that resist cellular stress. 
Cells under hydrogen peroxide stress showed an increase in number of individuals in the 
Ngb-transfected SH-SY5Y cells, while the Ngb-transfected cells pretreated with E2 and RES 
showed a decrease in individual number. These results show that Ngb overexpression alone 
could not inhibit mitochondrial fragmentation, but rather the synergistic effects of the ERβ 
agonists with Ngb overexpression abrogated the detrimental effects of fragmentation.  For the 
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network number, Ngb overexpression alone or with ERβ agonists pretreatment did not have any 
significant effect on the number of networks under hydrogen peroxide stress, indicating that the 
mitochondrial networks were being fragmented into more punctae and rod-shaped 
mitochondrion. 
As previously stated, increases in ROS production lead to mitochondrial fragmentation 
and apoptosis. ROS production has been shown to increase during hypoxia (Fridovich, 1978; 
Yoshikawa et al., 1982; Block et al., 1989; Chang et al., 1989; Kehrer et al., 1990), and 
reoxygenation (Arroyo et al., 1990), even though another study shows that hypoxic insults 
reduce ROS production (de Groot and Littauer, 1989). For the hypoxia/reoxygenation 
experiments, the Ngb-transfected SH-SY5Y cells with E2 and RES pretreatments as well as the 
E2-pretreated non-transfected cells showed a significant increase in individual number. These 
results show that Ngb overexpression combined with E2 and RES did not inhibit fission.  
The number of mitochondrial individuals in the hypoxic experimentation showed a 
significant increase in Ngb-transfected SH-SY5Y cells and those that have been transfected with 
Ngb and pretreated with E2. This indicates that Ngb overexpression alone as well with E2 
pretreatment did not inhibit the formation of more punctae and rod-shaped mitochondrion. 
However, Ngb overexpression and RES pretreatment showed a significant decrease in the 
number of individuals, which agrees with RES‘s role at ameliorating mitochondrial fission 
(Wang et al., 2014; Li et al., 2016). As for the number of networks, there was a significant 
increase in cells overexpressing Ngb, as well pretreated with E2 and RES, indicating that larger 
networks are being fragmented into smaller networks. The absence of fission amelioration could 
be as a result of low E2 and RES concentrations (10 µM) or that the pretreatment period (24 
hours) was relatively short for the hypoxia/reoxygenation stress cells. Wang et al., 2014 showed 
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that a higher RES concentration and a longer pretreatment period do attenuate mitochondrial 
fission. 
In addition to individual and network numbers, the number of branches per network 
(mean network size) was assessed as an indication of fusion or hyperfusion, as the networks 
elongated and become highly interconnected; Ngb overexpression did not show any significant 
effects on the number of branches, indicating that Ngb does not promote mitochondrial fusion. 
These results suggest that the mechanism of action for Ngb does not involve induction of 
mitochondrial fusion, nor the inhibition of mitochondrial fission. Its anti-apoptotic effects, 
although not fully elucidated, could lie simply ROS scavenging (Herold et al., 2004; Fordel et 
al., 2006; Fordel et al., 2007; Li et al., 2008; Fago et al., 2008; Burmester and Hankeln, 2009), 
nitric oxide modulator (Herold et al., 2004; Brunori et al., 2005) and GDI inhibition (Watanabe 
et al., 2012). Moreover, the binding of Ngb to a plasma membrane lipid raft associated protein 
Flotillin-1 (Watanabe et al., 2012), could enforce the absence of a Ngb role in mitochondrial 
fusion promotion. Furthermore, Raychaudhuri et al., 2010 transfected SH-SY5Y cells with a 
Ngb-expressing plasmids that increased Ngb levels to 5 µM; this concentration was shown to 
protect cells against the stressor HA14-1 (BH3 mimetic) at low concentrations (12.5 µM and 25 
µM) (Raychaudhuri et al., 2010), which shows that overexpression of Ngb was able to protect 
the cells from low-level stress, indicating that the stressors imposed onto the cells in this study 
could have been a high-level stress for Ngb to protect the cells. To provide further insight into 
Ngb‘s mechanism of action, cell viability after transfection, intracellular ROS measurement and 
direct ROS scavenging assays could be undertaken. Also, the overexpression of EGFP-Ngb 
fusion protein after transfection could provide more direct quantifications of mitochondrial 
network characteristics.  
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7.0 Appendix  
 
 
 
 
 
 
 
 
 
 
Figure 1.1 Intrinsic Apoptotic Pathway 
The figure depicts the intrinsic apoptotic pathway. The release of cytochrome c from 
the mitochondrion into the cytosol, leads to the formation of the apoptosome. The 
apoptosome activates procaspase-9 into caspase-9 that activates the caspase cascade, 
inexorably leading to apoptosis. The image was obtained from Logue and Martin, 2008. 
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Figure 1.2 Electron Transport Chain in the Inner Mitochondrial Membrane 
The figure depicts the complexes embedded within the inner mitochondrial membrane 
that are responsible for transport of electrons. The sites at which ROS are produced is 
portrayed as the red shapes. The image was obtained from Orr et al., 2013. 
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Figure 1.3 Apoptotic Signalling Pathway 
The figure depicts both the extrinsic and the intrinsic apoptotic pathway. The bottom 
left corner of the figure shows the release of cytochrome c from the mitochondrion into 
the cytosol, forming the apoptosome. The apoptosome activates procaspase-9 into 
caspase-9 that will eventually lead to apoptosis. The image was obtained from Yong-
ling et al., 2008. 
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Figure 1.4 Estrogen Receptor Structure 
The figure depicts the structural overview of the estrogen receptors. The top 
structure portrays the ERα and the bottom structure pertains to ERβ. The 
numbers on the structures represent the amino acid sequences, and the domains 
are labeled from A to F; domains A and B form the N-Terminal Domain, and E 
and F form the Ligand Binding Domain. AF: Activation Function 
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Figure 1.5 Three “Over” Three Globin Fold Structure 
Overview 
The figure depicts the globin fold of Ngb, comprised of 8 α-
helical segments labeled from A to H. The three over three 
fold involves 3 helices B, G and H ―over‖ the 3 helices A, E 
and F. The haem group is ―sandwiched" within the fold. The 
image was obtained from Pesce et al., 2002.  
Figure 1.6 Stereo View of the Hexacoordinate Haem 
The residues HisE7 (distal), HisF8, LeuF4, ValFG2, ValFG4, and PheG5 
(proximal) are depicted. The HisE7 and HisF8 residues assume an orthogonal 
orientation. The image was obtained from Pesce et al., 2003. 
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Figure 1.7 Primary Structure of Ngb with ERK and 14-3-3 Binding Sites 
The residues HisE7 and HisF8 that coordinate the haem group are highlighted in 
yellow, the residues comprising the 14-3-3 binding sites are highlighted in green 
and the pink highlight represents the ERK docking site. The letters in dark 
represent the phosphorylation of PKA and ERK. 
Figure 1.8 Primary Structures of the Globins Ngb, Mb and Hb 
The top amino acid sequence represents myoglobin, the second and third amino acid 
sequences represent haemoglobin (α and β respectively) and the bottom line 
represents neuroglobin. The residues HisE7 and HisF8 that coordinate the haem group 
are highlighted in yellow on the Ngb sequence. The residues that come into contact 
with the haem group are italicized, underlined and in bold. 
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Figure 1.9 Protein Import into Mitochondrion 
The complexes TOM, TIM23 and TIM22 are responsible for importing 
proteins destined to the internal compartments, while the Export complex 
is responsible for exporting proteins from the matrix and into the inner 
membrane. The specific receptor (R) is the site of binding for proteins 
with the N-terminal sequence or internal signals, which then directs the 
protein through the general import pore (GIP) of the translocase of the 
outer membrane (TOM). The proteins with the N-terminal presequence 
are imported across the inner membrane via the TIM23 complex and into 
the matrix. The proteins with the internal targeting sequences are destined 
for the inner membrane, and are directed by the Tim factors to the TIM22. 
Membrane insertion at the TIM22 complex is dependent on the membrane 
potential. The export complex export proteins that are encoded in the 
mitochondria and some imported proteins to the inner membrane. IM: 
inner membrane; IMS: intermembrane space; OM: outer membrane. The 
image was obtained from Truscott et al., 2003. 
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Figure 2.1: Neuroglobin does not inhibit Cytochrome c Peroxidase Activity    
The bar chart shows the three different experimental conditions: cytochrome c 
alone (negative control), cytochrome c with cardiolipin (positive control) and 
cytochrome c with cardiolipin and neuroglobin. The bars represent means ± SEM 
from triplicates for each condition. The statistical analysis between the positive 
control (a1) and the experimental condition (a2) were analyzed with the 
independent T-test (p-value = 0.24). ** indicates a p-value less than 0.001. 
** 
b 
a 1 
a 2 
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Figure 2.2 H2O2-Induced oxidation 
chemiluminescence response 
The figure depicts the oxidation of luminol via 
H2O2 in a manner similar to the Amplex Red 
reagent. The red curve shows cyt c with 
cardiolipin, while the black dotted curve shows 
cyt c without cardiolipin. 
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Figure 3.1 Western Blot Visualization of Ngb 
The images of the membranes show the attempted detection of 
Ngb after treatment with 10 nM E2, vehicle and negative controls 
for 24 hours. The top image shows Ngb detection and the bottom 
image shows tubulin loading control. 
Ladder Purified Ngb 
17 kDa 
Ngb 
Figure 3.2 Western Blot Visualization of Purified Ngb 
The images of the membrane show the detection of 2 µg of 
purified Ngb.  
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Figure 3.3 Western Blot Visualization of Ngb with 
Different E2 Concentrations and Plasmid Variant 
Transfections 
The image of the membrane shows the detection of Ngb after 
treatment of different E2 concentrations and negative control for 
24 hours. The last three lanes show the attempted detection of 
Ngb bands after SH-SY5Y transient transfection; the Ngb bands 
appear in the last two lanes. 
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Figure 3.4 Western Blot Visualization of Ngb after 
Treatment with 10 µM E2 or RES for 24 hours 
The top half images of the membranes show the detection of Ngb 
after treatment of a) E2 and b) RES. The bottom half images of a) and 
b) show the actin loading control. 
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Figure 3.5 Ngb mRNA Transcript Levels in SH-SY5Y with 
OGD and Hypoxia 
The hypoxia and OGD PCR was used as a positive control for the 
success of the technique. The mRNA level is greatly upregulated in 
OGD, but is not significant in hypoxia. The housekeeping gene used 
here is GAPD.  
** 
Control Hypoxia OGD 
Control 
DMSO E2 E2 DMSO Control 
Figure 3.6 Ngb mRNA Transcript Levels in MCF-7 and DLD-1 cells 
after 10 nM E2 stimulation for 24 hours 
The figure depicts the levels of Ngb mRNA transcripts after 24 hour stimulation 
with 10 nM E2. a) Shows the mRNA transcript expression level in MCF-7 and b) 
shows the mRNA transcript expression level in DLD-1. The housekeeping genes 
used here are GAPD and PPIA.  
a b 
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EGFP Brightfield Merge 
Ngb-EGFP Brightfield Merge 
Figure 3.7 Confocal Microscope Live Images of EGFP Alone Protein 
and the Ngb-EGFP Fusion Protein 
The images depict the images of SHY-SY5Y cells after the transfection of EGFP 
alone plasmid construct and the Ngb-EGFP fusion plasmid construct. a) Shows 
the fluorescence of the EGFP, with the brightfield channel being used to create 
contrast to view both transfected and non-transfected cells. These images were 
captured at 350 ms exposure time. b) Shows the fluorescence of the Ngb-EGFP 
fusion protein, with the brightfield channel being used to create contrast to view 
both transfected and non-transfected cells. These images were captured at 1500 
ms exposure time.  
a 
b 
Figure 3.8 Western blot of SH-SY5Y cells underwent Hypoxic and 
OGD insult 
The images depict the visualization of Ngb bands in SH-SY5Y cells that 
underwent hypoxic and OGD insults to confirm the difference in Ngb 
expression obtained from the qRT-PCR. The top half depicts the western 
blot of the hypoxia experiment and the OGD experiment for the 
visualization of Ngb. The bottom half depicts the western blot of Actin, 
the loading control.  
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Figure 3.9 Gel electrophoresis after PCR amplification of Ngb 
The image depicts the amplification of Ngb bands from the pCMV3-
GFPSpark-Ngb obtained from Sino Biological Inc.    
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Figure 3.10 Gel electrophoresis after restriction enzyme cutting 
reactions of mEmerald Mito-7 plasmid 
The image depicts the separation of EGFP and the mitochondrial 
targeting sequence (MTS) after the cutting reaction using restriction 
enzymes. The left half of the image shows the cutting reaction with the 
enzymes NheI and NotI to separate EGFP and MTS from the plasmid 
backbone. The second half of the image shows the cutting reaction with 
the enzymes NheI and BamHI to separate MTS only. 
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Figure 3.11 Diagrams depicting the construct of the plasmids for the 
transfection experiments 
The images depict the graphic mapping of the plasmids with Ngb-EGFP 
fusion, Ngb alone and EGFP alone after Gibson Assembly. The maps 
were obtained by using A plasmid Editor (ApE), a program developed by 
M. Wayne Davis. from the plasmid backbone. The different sequences 
are highlighted by different colours. 
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Figure 3.12 Gel electrophoresis of colony PCR to assess proper 
insertion at the seams after Gibson Assembly 
The image depicts the separation of the Ngb-EGFP fusion and Ngb alone 
after colony PCR.  The Ngb alone band lies at the correct size, and the 
Ngb-EGFP fusion sequence lies at the approximate correct size, 
indicating the success of the Gibson Assembly. The plasmids were sent to 
the Sickkids Lab to confirm the correct sequences, and the results have 
confirmed that sequences are in alignment.   
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Table 3.1 Cq levels for the Ngb mRNA transcripts in MCF-7 cells treated with 
E2, vehicle and negative control for 24 hours 
The tables show the Cq levels for the Ngb mRNA transcripts in MCF-7 cells. The 
table on the left depicts the Cq levels for the MCF-7 cells treated with 10 nM E2 for 
24 hours alongside the NRT Cq levels. The table in the middle depicts the Cq levels 
for the MCF-7 cells treated with the vehicle for 24 hours alongside the NRT Cq 
levels. The table on the right depicts the Cq levels for the MCF-7 cells without any 
treatment alongside the NRT Cq levels. 
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Table 3.2 Cq levels for the Ngb mRNA transcripts in MCF-7 cells treated with 
E2 for 4 hours or 24 hours 
The tables show the Cq levels for the Ngb mRNA transcripts in MCF-7 cells. The 
table on the left depicts the Cq levels for the MCF-7 cells treated with 10 nM E2 for 
24 hours alongside the NRT Cq levels. The table in the middle depicts the Cq levels 
for the MCF-7 cells treated with 10 nM E2 for 24 hours and then treated with 
DNAse alongside the NRT Cq levels. The table on the right depicts the Cq levels for 
the MCF-7 cells treated with 10 nM E2 for 4 hours alongside NRT Cq levels. 
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Figure 3.13 Expression levels of Ngb and VEGF in normoxia and 
hypoxia 
The image depicts the expression levels of Ngb and VEGF mRNA 
transcripts under normoxic and hypoxic conditions. VEGF mRNA level 
upregulation in hypoxia was used as a positive control for the hypoxic 
experiments. 
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Figure 3.14 Western blots images for different 
transfer times and voltages for semi-dry transfer 
The images show the detection of neuroglobin bands in the 
top halves and show the loading controls in the bottom 
halves. a) depicts the visualization attempt at the transfer 
settings: 15V under 15 minutes and b) 15V under 30 minutes. 
c) portrays the visualization attempt at the transfer settings: 
25V under 15 minutes. 
a 
b 
c 
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Figure 3.15 Western blots images for different transfer 
buffer for semi-dry transfer 
The image shows the detection of neuroglobin band in the top 
half and shows the loading control in the bottom half. The 
transfer was done using a different transfer buffer (Bjerrum 
Schaefer-Nielson Buffer). 
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Figure 4.1 Mitochondrial fusion and fission 
The figure depicts the GTPases that control 
fusion and fission and the process that they 
undertake. a) portrays OPA1 and Mfn and the 
process of mitochondrial fusion. b) portrays 
Drp1 and the process of mitochondrial fission. 
Figure 4.2 Skeletonizing Mitochondrial Network of 
Stable-Transfected SH-SY5Y 
The image on the left shows an image from Carl Zeiss 
microscope, with the mitochondrial network coloured green. 
The image on the right depicts MiNA skeletonization for 
quantification. 
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Figure 4.3 Quantification of Mitochondria based on 
Different Shapes 
The image on the left depicts mitochondrial networks, with 
different mitochondrial shapes being highlighted in yellow. 
The diagrams on the right portray the different shapes that 
assess fusion or fission, with networks indicating fusion and 
individuals indicating fission. The image was obtained from 
Valente et al., 2017. 
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Figure 4.4 Quantification of Mitochondrial Individuals after Estradiol Pretreatment 
under Hydrogen Peroxide Stress 
The figures portray the differences in the number of mitochondrial individuals. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under H2O2 stress. (b) shows the comparison between the 
non-transfected SH-SY5Y cells under H2O2 stress with the Ngb-transfected SH-SY5Y cells 
under H2O2 stress. (c) shows the comparison between the Ngb-transfected SH-SY5Y cells 
under H2O2 stress and Ngb-transfected SH-SY5Y cells under H2O2 stress after estradiol 
pretreatment. Data is represented as mean ± SEM. 
*: indicates p-value <0.05 
**: indicates p-value <0.01 
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Figure 4.5 Quantification of Mitochondrial Networks after Estradiol Pretreatment under 
Hydrogen Peroxide Stress 
The figures portray the differences in the number of mitochondrial networks. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under H2O2 stress. (b) shows the comparison between the 
non-transfected SH-SY5Y cells under H2O2 stress with the Ngb-transfected SH-SY5Y cells 
under H2O2 stress. (c) shows the comparison between the Ngb-transfected SH-SY5Y cells 
under H2O2 stress and Ngb-transfected SH-SY5Y cells under H2O2 stress after estradiol 
pretreatment. Data is represented as mean ± SEM. 
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Figure 4.6 Quantification of Mitochondrial Mean Network Sizes after Estradiol 
Pretreatment under Hydrogen Peroxide Stress 
The figure portrays the differences in the number of mitochondrial branches per network. 
The left side of the figure depicts the non-transfected SH-SY5Y cells under various 
conditions of treatments, while the right side of the figure depicts the Ngb-transfected 
SH-SY5Y cells under the same conditions of treatment. Data has been normalized to the 
controls of each form of transfection and is represented as mean ± SEM. 
Figure 4.6 Quantification of Mitochondrial Mean Network Sizes after Estradiol 
Pretreatment under Hydrogen Peroxide Stress 
The figure portrays the differences in the number of mitochondrial branches per network. 
The left side of the figure depicts the non-transfected SH-SY5Y cells under various 
conditions of treatments, while the right side of the figure depicts the Ngb-transfected 
SH-SY5Y cells under the same conditions of treatment. Data has been normalized to the 
controls of each form of transfection and is represented as mean ± SEM. 
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Figure 4.7 Quantification of Mitochondrial Individuals after Resveratrol Pretreatment 
under Hydrogen Peroxide Stress 
The figures portray the differences in the number of mitochondrial individuals. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under H2O2 stress. (b) shows the comparison between the 
non-transfected SH-SY5Y cells under H2O2 stress with the Ngb-transfected SH-SY5Y cells 
under H2O2 stress. (c) shows the comparison between the non-transfected SH-SY5Y cells 
under H2O2 stress and Ngb-transfected SH-SY5Y cells under H2O2 stress after resveratrol 
pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value <0.01 
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Figure 4.8 Quantification of Mitochondrial Networks after Resveratrol Pretreatment 
under Hydrogen Peroxide Stress 
The figures portray the differences in the number of mitochondrial networks. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under H2O2 stress. (b) shows the comparison between the 
non-transfected SH-SY5Y cells under H2O2 stress with the Ngb-transfected SH-SY5Y cells 
under H2O2 stress. (c) shows the comparison between the non-transfected SH-SY5Y cells 
under H2O2 stress and Ngb-transfected SH-SY5Y cells under H2O2 stress after resveratrol 
pretreatment. Data is represented as mean ± SEM. 
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Figure 4.9 Quantification of Mitochondrial Mean Network Sizes after Resveratrol 
Pretreatment under Hydrogen Peroxide Stress 
The figure portrays the differences in the number of mitochondrial branches per network. 
The left side of the figure depicts the non-transfected SH-SY5Y cells under various 
conditions of treatments, while the right side of the figure depicts the Ngb-transfected 
SH-SY5Y cells under the same conditions of treatment. Data has been normalized to the 
controls of each form of transfection and is represented as mean ± SEM. 
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Figure 4.10 Quantification of Mitochondrial Individuals after Estradiol Pretreatment 
under Hypoxic Stress 
The figures portray the differences in the number of mitochondrial individuals. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under hypoxic stress. (b) shows the comparison between 
the non-transfected SH-SY5Y cells under hypoxic stress with the Ngb-transfected SH-SY5Y 
cells under hypoxic stress. (c) shows the comparison between the Ngb-transfected SH-
SY5Y cells under hypoxic stress and Ngb-transfected SH-SY5Y cells under hypoxic stress 
after estradiol pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value <0.01 
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Figure 4.11 Quantification of Mitochondrial Networks after Estradiol Pretreatment 
under Hypoxic Stress 
The figures portray the differences in the number of mitochondrial networks. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under hypoxic stress. (b) shows the comparison between 
the non-transfected SH-SY5Y cells under hypoxic stress with the Ngb-transfected SH-SY5Y 
cells under hypoxic stress. (c) shows the comparison between the non-transfected SH-
SY5Y cells under hypoxic stress and Ngb-transfected SH-SY5Y cells under hypoxic stress 
after estradiol pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value < 0.01 
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Figure 4.12 Quantification of Mitochondrial Mean Network Sizes after Estradiol 
Pretreatment under Hypoxic Stress 
The figure portrays the differences in the number of mitochondrial branches per network. 
The left side of the figure depicts the non-transfected SH-SY5Y cells under various 
conditions of treatments, while the right side of the figure depicts the Ngb-transfected 
SH-SY5Y cells under the same conditions of treatment. Data has been normalized to the 
controls of each form of transfection and is represented as mean ± SEM. 
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Figure 4.13 Quantification of Mitochondrial Individuals after Resveratrol Pretreatment 
under Hypoxic Stress 
The figures portray the differences in the number of mitochondrial individuals. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under hypoxic stress. (b) shows the comparison between 
the non-transfected SH-SY5Y cells under hypoxic stress with the Ngb-transfected SH-SY5Y 
cells under hypoxic stress. (c) shows the comparison between the Ngb-transfected SH-
SY5Y cells under hypoxic stress and Ngb-transfected SH-SY5Y cells under hypoxic stress 
after estradiol pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value <0.01 
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Figure 4.14 Quantification of Mitochondrial Networks after Resveratrol Pretreatment 
under Hypoxic Stress 
The figures portray the differences in the number of mitochondrial networks. (a) shows 
the comparison between the non-transfected SH-SY5Y cells of the control group with the 
Ngb-transfected SH-SY5Y cells under hypoxic stress. (b) shows the comparison between 
the non-transfected SH-SY5Y cells under hypoxic stress with the Ngb-transfected SH-SY5Y 
cells under hypoxic stress. (c) shows the comparison between the non-transfected SH-
SY5Y cells under hypoxic stress and Ngb-transfected SH-SY5Y cells under hypoxic stress 
after estradiol pretreatment. Data is represented as mean ± SEM. 
**: indicates p-value < 0.01 
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Figure 4.15 Quantification of Mitochondrial Mean Network Sizes after Resveratrol 
Pretreatment under Hypoxic Stress 
The figure portrays the differences in the number of mitochondrial branches per network. 
The left side of the figure depicts the non-transfected SH-SY5Y cells under various 
conditions of treatments, while the right side of the figure depicts the Ngb-transfected 
SH-SY5Y cells under the same conditions of treatment. Data has been normalized to the 
controls of each form of transfection and is represented as mean ± SEM. 
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Figure 4.7 Western blot of SH-SY5Y cells that were pretreated with E2 or 
RES during H2O2 insult to confirm successful transfection 
The images depict the visualization of Ngb bands in SH-SY5Y cells that were 
pretreated with E2 or RES during H2O2 insult to confirm the success of 
transfection. The top half depicts the western blot of Ngb and the loading control 
actin after the pretreatment of RES during H2O2 insult. The bottom half depicts the 
western blot of Ngb and the loading control actin after the pretreatment of E2 
during H2O2 insult.  
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Figure 4.8 Western blot of SH-SY5Y cells that were pretreated with E2 or 
RES without any stress to confirm successful transfection 
The images depict the visualization of Ngb bands in SH-SY5Y cells that were 
pretreated with E2 or RES without any stress or insult to confirm the success of 
transfection. The top half depicts the western blot of Ngb after the pretreatment 
with E2 or RES. The bottom half depicts the western blot of the loading control 
Actin. 
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Figure 4.9 Western blot of SH-SY5Y cells that were pretreated with E2 or 
RES under hypoxic insult to confirm successful transfection 
The images depict the visualization of Ngb bands in SH-SY5Y cells that were 
pretreated with E2 or RES under hypoxic insult to confirm the success of 
transfection. The top half depicts the western blot of Ngb and the loading control 
actin after the pretreatment with E2 under hypoxic insult. The bottom half depicts 
the western blot of Ngb and actin after the pretreatment with RES under hypoxic 
insult. 
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Figure 5.1 Docking Structure of Ngb-Cytochrome c 
Complex 
The figure depicts a physical interaction between cyt c and 
Ngb, where the Lys25 and Lys72 on cyt c bind with Gluc67 
and Glu60 on Ngb. This structure was calculated using 
BIGGER (Palma et al., 2000) and rendered using YASARA. 
This image was obtained from Raychaudhuri et al., 2010.  
